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ABSTRACT
Extractives from the Amaryllidaceae family were studied in this work. Plants of the
monocotyledonous family Amaryllidaceae are widely distributed. These plants occur
abundantly and natively in the tropics and are very prominent in South Africa.
Subterranean bulbs with thick fleshy scales or rhizomes are characteristic of this
family. This family is known to be rich in alkaloids. Specific alkaloids, not found in
other plants, are consistently found in the family. In South Africa, bulbs of the
Amaryllidaceae family have, for at least 200 years, been used as traditional medicine.
Two species, Cyrtanthus breviflorus and Brunsvigia radulosa were examined. Both
species are protected by the South African Flora Protection Act, 2000. These species
had not been fully investigated previously. Brunsvigia radulosa Herb. was obtained
from Mpumalanga and Cyrtanthus breviflorus Harv. from Kwazulu-Natal.
Cyrtanthus breviflorus, commonly known as Wild Crocus, is found along the coastal
regions from the Eastern Cape to Kenya. The bulb of this plant is edible. The plant is
used traditionally to treat intestinal worms (round and tape worms) and as love and
protective charms. The ethanol extract of this plant yielded four alkaloids,
haemanthamine, crinamine hydrochloride, tazettine and lycorine. The hexane extract
yielded the known triterpenoids: lupeol, lupenone, glochidone, 3~,27-dihydroxylup­
20(29)-ene and betulinaldehyde. Triterpenoids have not been previously isolated from
Cyrtanthus.
Brunsvigia radulosa can be found in grassland areas from north-western Cape to the
northern parts of South Africa. The hard bulbs of this plant are used to seal clay pots.
This species is used in traditional medicine to straighten bones of children and to treat
barrenness in women as well as facilitating an easy birth. The ethanol extract of this
plant was rich in crinamine. Other alkaloids obtained included lycorine, 1-0-acetyl-
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1.1 AN INTRODUCTION TO THE ALKALOIDS
The term alkaloid is usually applied to basic, nitrogen-containing compounds of plant
origin. Alkaloids have complex molecular structures, and they manifest significant
pharmacological activity [1].
Alkaloids have diverse and important physiological effects on both humans as well as
animals. Well known alkaloids include ephedrine (1), nicotine (2), morphine (3),







Figure 1.1. Well known alkaloids [1,2]
Alkaloids are found commonly in certain families of flowering plants. More than
3,000 different types of alkaloids have been identified in a total of more than 4,000
plant species [3]. In general, a given species contains only a few types of alkaloid,
though both the Opium poppy (Papaver somniferum) and the Ergot fungus
,
(Claviceps) each contain about 30 different types. Certain plant families are
particularly rich in alkaloids; all plants of the poppy family (Papaveraceae) are
thought to contain them. The Ranunculaceae (buttercups), Solanaceae (nightshades),
and Amaryllidaceae (Amaryllis) are other prominent alkaloid-containing families [3].
A few alkaloids have been found in animal species, such as the New World beaver
(Castor canadensis) and poison-dart frogs (PhyUobates) [2,3].
The function of alkaloids in plants is not fully understood. It has been suggested that
they are simply waste products of plants' metabolic processes, but evidence suggests
that they may serve specific biological functions [2]. In some plants, the concentration
of alkaloids increases just prior to seed formation and then drops off when the seed is
ripe. This suggests that alkaloids may play a role in seed formation. Alkaloids may
also protect some plants from destruction by certain insect species [1,3].
The chemical structures of alkaloids are extremely variable. Generally an alkaloid
contains at least one nitrogen atom in an amine-type structure. This or another
nitrogen atom can be active as a base in acid-base reactions. The name alkaloid
("alkali-like") was originally applied to the substances because they react with acids
to form salts [~2,3,4,5]. Most alkaloids have one or more of their nitrogen atoms as
part of a ring of atoms. Alkaloid names generally end in the suffix -ine, a reference to
their chemical classification as amines. In their pure form most alkaloids are
colourless, nonvolatile, crystalline solids. They also tend to have a bitter taste [2,3].
Interest in the alkaloids stems from the wide variety of physiological effects, both
wanted and unwanted, they produce in humans and other animals. Their use dates
back to ancient civilizations, but scientific study of these compounds had to await the
growth of organic chemistry as their structures are quite complex. The first alkaloid
to be isolated and crystallized was the potent active constituent of the opium poppy,
morphine, in 1805 [1,3].
The medicinal properties of alkaloids are quite diverse. Morphine (3) is a powerful
narcotic used for the relief of pain, but its addictive properties limit its usefulness.
Codeine, the methyl ether derivative of morphine found in the opium poppy, is an
excellent analgesic that is not as addictive [3]. Certain alkaloids act as cardiac or
respiratory stimulants. Quinidine, which is obtained from plants of the genus
Cinchona, is used to treat arrhythmias, or irregular rhythms of the heartbeat. Many
alkaloids affect respiration, but in a complicated manner such that severe respiratory
depression may follow stimulation. Ergonovine, from the fungus Claviceps purpurea,
and ephedrine (1), from Ephedra species, can act as blood-vessel constrictors [3].
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Many alkaloids possess local anaesthetic properties. Cocaine, from Erythroxylum
coca, is a very potent local anaesthetic. Quinine (4) is a powerful anti-malarial agent.
It was formerly the drug of choice for treating this disease, though it has been
replaced by less toxic and more effective synthetic drugs [4]. The alkaloid
tubocurarine is the active ingredient in the South American arrow poison, curare,
obtained from Chondrodendron tomentosum, and is used as a muscle relaxant in
surgery. Two alkaloids, vincristine and vinblastine, from Vinca rosea, are widely used
as chemotherapeutic agents in the treatment ofmany types ofcancer [3,4].
Nicotine (2) obtained from the tobacco plant Nicotiana tabacum is the principal
alkaloid and chief addictive ingredient of the tobacco smoked in cigarettes, cigars, and
pipes [3,4]. Some alkaloids are illicit drugs and poisons. These include the
hallucinogenic drugs from Anhalonium species and psilocybin from Psilocybe
mexicana. Synthetic derivatives of the alkaloids morphine and lysergic acid produce
heroin and LSD, respectively. The alkaloid coniine is the active component of the
poison hemlock (Conium maculatum) [3,4]. Strychnine (5), from Strychnos species, is
another powerful poison and was once used to control rodents [2,3,4].
Recently, two anti-HIV alkaloids nitidine (6) and magnoflorine (7) were found.
Nitidine inhibited human lyrnphoblastoid cell killing by HIV-1 and magnoflorine
showed anti-HIV activity with partial cytoprotection [6,7].
6 7
Figure 1.2: Recently discovered anti-HIV alkaloids [6,7]
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1.2 THE AMARYLLIDACEAE ALKALOIDS
1.2.1 INTRODUCTION
The Amaryllidaceae is the family of Amaryllis and related plants. Members of the
giant group Lilianae, the amaryllids are mostly bulbous plants, although some have a
rhizome. The flowers are bisexual and quite regular; they characteristically appear in
umbels at the top of a leafless stalk, the scape. The leaves are all produced from the
base of the plant; most species are deciduous, but Clivia is evergreen [8].
The family Amaryllidaceae is monocotyledonous and is fairly well distributed. These
plants occur abundantly in the tropics and are quite prominent in southern Africa,
where the family is most diverse (18 genera; ca. 280 species) [9]. The
Amaryllidaceae alkaloids are representative of a well established group of
isoquinoline alkaloids [9]. These alkaloids, which are not found in other plants, are
consistently found in the Amaryllidaceae family [10]. The high water content of the
bulbs in the family limits the total alkaloid content to a maximum of 1-2 percent
[10,11].
Bulbs of the Amaryllidaceae have, for several decades, been used as traditional
medicine. Although sometimes whole plants are used, frequently it occurs that either
a cold or warm infusion of bulbs is ingested orally or applied to a designated area.
Some examples of traditional medicinal usage of some species of Amaryllidaceae in
South Africa is described below in table 1 [12].
Table 1.1: Medicinal usage of some South African Amaryllidaceae [12]
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Some Amaryllidaceae alkaloids also exhibit a toxic and a hallucinogenic effect. In
smaller doses symptoms such as excessive salivation, emesis and diarrhoea are
evident. At higher doses the Amaryllidaceae alkaloids can cause CNS excitation or
depression, and may even be fatal. Consequently, the Amaryllidaceae alkaloids have
been used as a source ofpoison [10,12].
It is well known that Boophane disticha can cause profound hallucinations. It is used
in Basuto initiation ceremonies: consumption of a prepared alkaloidal concoction
leads to intoxication which symbolizes the inhabitation of the spirit ofmanhood in the
boys [12].
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1.2.2 CLASSIFICATION OF THE AMARYLLIDACEAE
ALKALOIDS
Alkaloids are often classified on the basis of their chemical structure. For example,
those alkaloids that contain an indole ring system are known as indole alkaloids. On
this basis, the principal classes of alkaloids are the pyrrolidines, pyridines, tropanes,
pyrrolizidines, isoquinolines, indoles, quinolines, and the terpenoid and steroidal
alkaloids. Alternatively, alkaloids can be classified according to the biological system
in which they occur. For example, the opium alkaloids occur in the opium poppy
(Papaver somniferum) [1,3]. This dual classification system has been, successfully,
in use for a very long time [3].
The Amaryllidaceae family produces the class of isoquinoline alkaloids that are
biosynthetically derived from the amino acids tyrosine and phenylalanine [9,11].
Almost all Amaryllidaceae alkaloids can be considered to be derived from a nucleus
of fifteen carbon atoms comprised of two fragments, an aromatic C6-Cl unit and a C6-
C2 moiety [11]. Variations in the degree of oxygenation, hydrogenation and
substitution within these fragments accounts for the numerous alkaloids that have
been isolated. The Amaryllidaceae alkaloids can be classified into eight different
types [13].
Table 1.2: The different Amaryllidaceae alkaloid types [13]
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Since only alkaloids of the 5,1 Ob-ethanophenanthridine, [2]benzopyrano[3,4c]indole
and lycorine type have been isolated in this investigation, only these will be discussed
in some detail. Briefmention of the other groups will be made.
1. The lycorine type alkaloids.
Lycorine is the most common isoquinoline alkaloid and is easily isolated because of
its relative insolubility. The lycorine type alkaloids consist of four rings and usually a
methylenedioxy substituent. The isoquinoline skeleton is formed by ring A and ring
B. Ring C is attached to the isoquinoline skeleton at C-l1b and C-l1c. Ring D is




Figure 1.3: An alkaloid of the lycorine type
Variations in the substitution pattern in rings A, C and D in lycorine, has led to the
class of alkaloids known as the lycorine type alkaloids. Interconversion of these
alkaloids can be achieved by simple hydrolytic, oxidative and reductive reactions.
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2. The homolycorine type alkaloids.
This type of alkaloids are characterized by an oxygen-containing heterogeneous B
ring and a five membered nitrogen containing D ring. Ring B constitutes a lactone
and the nitrogen atom in ring D is always methylated. Variations in the substitution





Figure 1.4: An alkaloid of the homolycorine type.
3. The galanthamine type alkaloids.
These type of alkaloids have a haemanthamine type skeleton with an open Bring.
These alkaloids are unique in that ring A and ring C are joined by an ether linkage.
These alkaloids also posses an a-orientated ethane nitrogen bridge. Ring C contains a




Figure 1.5: An alkaloid of the galanthamine type.
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4. The S,lOb-ethanophenanthridine type alkaloids.
Alkaloids derived from this ring system are very common in the Amaryllidaceae. The
5,lOb-ethanophenanthridine type alkaloids are further subdivided into the crinine type









Figure 1.6: Alkaloids of the S,lOb-ethanophenanthridine type
The distinction between the crinine and the haemanthamine type alkaloids lies in the
orientation of the 5-10b ethano bridge. In the former type of alkaloids, the bridge is
in a ~-orientation, while in the latter, it is in an a-position. Hydroxylations,
hydrogenation, methylation, acetylation and inversion of the stereochemical
configurations of substituents in crinine and haemanthamine result in the numerous
5,lOb-ethanophenanthridine type alkaloids.
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5. The [2]benzopyrano[3,4c]indole type of alkaloids.
[2]Benzopyrano[3,4c]indole type alkaloids have four rings. Ring A is aromatic with a
methylenedioxy substituent. Ring B has a heterocyclic oxygen atom. Ring C is a six
membered ring with a allylic methoxyl group. Ring D has a heterocyc1ic nitrogen
atom and this nitrogen atom is methylated. Tazettine may be an artefact, which





Figure 1.7: Alkaloids of the [2]benzopyrano[3,4c]indole type.
OMe
Pretazettine
6. The montanine type alkaloids.
The alkaloids of this group are distinguished by their seven membered nitrogen






Figure 1.8: An alkaloid of the montanine type
10
7. The isocarbostyril/narciclasine type alkaloids.
This group of alkaloids has only three rings and usually a methylenedioxy substituent
on ring A. These alkaloids can be distinguished by an amide group in ring B.






Figure 1.9: An alkaloid of the isocarbostyril/narciclasine type
8. Miscellaneous type alkaloids.
Alkaloids which cannot be grouped on the basis of the parent ring systems of groups
one to seven, are placed here. These compounds are considered as being either
trapped biosynthetic intermediates, rearrangement products related to known alkaloids
or possible artefacts [13].
Belladine
Figure 1.10: An alkaloid ofthe miscellaneous type.
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1.2.3 BIOSYNTHESIS OF AMARYLLIDACEAE
ALKALOIDS
Two important organic reactions play a vital role in the biosynthesis of alkaloids [14].
The first reaction is the Mannich reaction. This reaction involves the condensation of
an amine, an aldehyde and a carbanion .
I
-CS + -CRG +
I




Initially (stepl) formaldehyde reacts with a secondary amine to yield an iminium ion
and subsequently (step 2) the iminium ion reacts with the enol form of an active











Scheme 1.1: The mechanism of the Mannich reaction using acetone [14].
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The second reaction is the oxidative coupling of phenols. This reaction is of
particular importance in the biosynthesis of Amaryllidaceae alkaloids. The oxidative
coupling of phenols is a free radical process thatis catalyzed by enzymes [14].
Loss of an electron and a proton from phenol leads to a resonance-stabilized free
radical. Two free radicals can then undergo coupling in several ways (scheme 1.2)
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Scheme 1.2: Phenolic oxidative coupling [14].
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In 1957 Barton and Cohen suggested that the Amaryllidaceae alkaloids were all
related to an intermediate which is now known as norbelladine [15,16,17]. Tracer
experiments have proved this to be correct [16,17]. The norbelladine structure arises







Figure 1.12: Norbelladine and its structural precursors.
In some plants, norbelladine may readily anse from phenylalanine by the
hydroxylation of derived metabolites such as cinnamic acid (scheme 1.3) [20].
a)
OC~CHCOOH -NH1 ~ O~CH= CHCOOH [0]
- ~~ -
b)
HO< >C~fHCOOH -cOz~ HOO~C~CH2NH2
N~ -
Scheme 1.3: Norbelladine from phenylalanine [20].
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Barton and Cohen, were the first authors to propose a mechanism for the union of
pathways, leading to the various types of alkaloid structures encountered in the
Amaryllidaceae family [20]. They postulated the formation of three basic skeletons
(figure 1.13); each arising by an alternate mode of coupling of their common
precursor, norbelladine. All three pathways are now known to be correct and can be








MeO '7 ~I Meo~ I











Figure 1.13: The three pathways leading to the Amaryllidaceae alkaloids [20].
Since, only alkaloids of the lycorine, crinine, haemanthamine and tazettine type were
isolated in this investigation, only their biosynthesis will be discussed here in detail.
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The biosynthesis of lycorine.
Lycorine type alkaloids arise from norbelladine (scheme 1.4) [20]. Norbelladine is
first methylated to O-methylnorbelladine (1) and this is then followed by ortho-para
oxidative coupling. The pathway involves the formation of a carbon - nitrogen bond,
which occurs by the addition of the nitrogen atom to a dienone system. This leads to
the formation of norpluvine (2). The methylenedioxy group is formed by the ring
closure between the hydroxyl group and the adjacent methoxyl group in norpluvine
(2). Finally hydroxylation at C-2 yields lycorine (3). It can be proven by tritium











Scheme 1.4: The biosynthesis of lycorine [20].
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The biosynthesis of 5,10b-ethanophenanthridine type alkaloids.
As in the biosynthesis of lycorine, O-methylnorbelladine is the precursor for the
biosynthesis of 5,10b-ethanophenathridine type alkaloids (scheme 1.5) [17,20,21].
The difference here is that an alternate mode of coupling can be observed i.e. para-
para instead of ortho-para oxidative coupling. The basic framework is completed by
the nitrogen adding to the dienone system as was the case for lycorine biosynthesis.



























• orientation of the 5,1 Ob-ethanophenathridine bridge depends on
type of twisting of O-methylnorbelladine precursor
Scheme 1.5: The biosynthesis of crinine and haemanthamine type alkaloids
[17,20,21].
17
The ethane bridge can have either an a or a ~ orientation depending on the manner in
which O-methylnorbelladine twists. Consequently, two different series of alkaloids
arise within the 5,10b-ethanophl:mathridine type alkaloids. O-methylnorbelladine
twisting which leads to compounds with the ~ orientated ethane bridge constitute the
crinine series of alkaloids, whilst those with the a orientated 5,1 Ob ethanoic bridge are
referred to as the haemanthamine type alkaloids. Hydroxylation at C-11 of these
compounds is difficult to explain as this site lacks any formal activation. However
such examples are not infrequent in secondary plant metabolism [20].
The biosynthesis of tazettine.
Haemanthamine IS converted via the alkaloid haemanthidine into pretazettine
(scheme 1.6). Pretazettine then undergoes rearrangement, under mildly basic
conditions, to give tazettine. Tazettine is considered, by some, to be an artefact,
arising from the true alkaloid, pretazettine [13,22]. The conversion of pretazettine














Scheme 1.6: The biosynthesis of tazettine from haemanthamine [20]
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CHAPTER 2
Extractives from Brunsvigia radulosa
2.1 A REVIEW OF PREVIOUS WORK
The genus Brunsvigia (Amaryllidaceae) is one often genera of the tribe Amaryllideae
[1,2]. Brunsvigia is distributed over both summer and winter rainfall regions [3]. It
grows profoundly in the winter rainfall area of South Africa [1,2]. The characteristics
of Brunsvigia include large bulbs, prostrate or widely spreading leaves, large
inflorescence, round flowers on large stalks and curved stamens. There are
approximately sixteen species in South Africa [4].
Decoctions of the bulbs of Brunsvigia grandiflora are used by the Zulu as an oral
treatment for coughs and colds and as enemas for renal and liver complaints [5]. The
outer skin of the bulb of this plant is used by the Xhosa as a circumcision wound
dressing and it is reported to promote very rapid healing [5,6]. The bulbs of
Brunsvigia minor are also used as purgatives. In addition to this, bulb infusions are
used for abdominal ailments [6,7].
Rock paintings of Brunsvigia radulosa have been found in the Caledon River Valley
area, in Western Lesotho [8]. The significance of this arises from the fact that plants
were often painted to express their magical and / or medicinal properties as opposed
to their food value [9]. It is believed that Brunsvigia radulosa is a plant which can
induce psychoactive states when it is consumed [8]. A decoction of Brunsvigia
radulosa is used by the Southern Sotho as a remedy for barrenness [7]. It is also
known that excessive ingestion can cause necrodegenerative hepatitis [5]. The
pharmacological activity of the plant extract of Brunsvigia radulosa was shown to be
effective against the murine P-388 lymphocytic leukemia in vivo [1,10].
The chemical examination of the bulbs of Brunsvigia radulosa has revealed the
presence of alkaloids [7,54]. The main alkaloid was brunsvigine (5). It was observed
that summer bulbs yield brunsvigine (5), brunsvinine (structure unknown) and
crinamine (8) whereas autumn bulbs yield brunsvigine (5), crinamine (8) and lycorine
(1) [7]. Table 2.1 shows the Brunsvigia species examined and the alkaloids identified
from them.
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Table 2.1: Previously identified alkaloids from Brunsvigia
The bulb of an unidentified South African species ofBrunsvigia is reported to contain
a haemolytic sapogenin [7]. The alkaloids identified from Brunsvigia can be
classified, to date, into four distinct alkaloid types: the lycorine type, the
haemanthamine type, the montanine type and the galanthamine type.
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The Iycorine type
1 RI =Rz = OH, R3+~= -OCHzO-
2 RI =Rz =OAc, R3+~=-OCHzO­





Figure 2.1: Previously isolated Iycorine type compounds from Brunsvigia.
Lycorine (1) is a widely distributed alkaloid in the Amaryllidaceae family and it has
been isolated from over thirty genera. There has been substantial interest in the.
synthesis of lycorine and its derivatives [11]. Among the phenanthridine alkaloids,
lycorine (1) is considered to be the most important because of its biological activity
[12]. The bioactivity of lycorine and lycorine type alkaloids, previously isolated from
South African species ofBrunsvigia, are given in table 2.2.
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Figure 2.2: Previously isolated montanine type alkaloid from Brunsvigia.
Only one alkaloid of the montanine type has been isolated from Brunsvigia.
Brunsvigine (5) has been isolated, together with brunsvinnine, crinamine and lycorine





Figure 2.3: Previously isolated galanthamine type alkaloids from Brunsvigia.
Galanthamine (6) and lycoramine (7) have been isolated from Brunsvigia species.
Galanthamine is used for its anticholinesterase activity in the treatment of
disturbances in the peripheral sympathetic synaptic transmission [24]. It is also used
in pharmaceutical drugs for the treatment of alcoholism and Alzheimer's disease [16].
Lycoramine produces acute poisoning of the cardiovascular, neuromuscular and







8 RI = OMe, Rz = H
9* RI =OMe, Rz=OHa/p
10 RI = OH, Rz = H
11 RI =OAc, Rz =H
* mixture of two epimers
Figure 2.4: Previously isolated haemanthamine type alkaloid from Brunsvigia.
Crinamine (8), is a powerful transient hypotensive agent in dogs. It shows respiratory
depressant activity [16,19]. Crinamine has also shown strong cytotoxic and moderate
antimalarial activity [26]. 6-Hydroxycrinamine (9) is isolated as a mixture of isomers.
Hamayne (10) and 3-0-hamayne (11) are well known alkaloids in the Amaryllidaceae
family. Haemanthidine (12) is active against A-431, KB, Lul, Mel2 and ZR-75-1
cell lines. It has shown significant activity against LnCaP and HT cell lines [ 27].
The crinine type
R3
13 R) = OH a., R2 = H, R3 = H
14 R)=OMeo., R2=H, R3=H
15 R) = OMe 13, R2= H, R3 = H
16 R)=OMeo., RrH, R3=OMe





18 R) = OAc 13, R2 = OAc, R3 = OMe
19 RI =OH 13, R2=OH, R3=OMe
20 R) = OAc /3, R2 = OAc, R3= H





24 RI = OMe, R2 = OMe
Figure 2.5: Previously isolated crinine type alkaloids from Brunsvigia
Crinine (13), buphanisine (14), epibuphanisine (15), buphanidrine (16), brunsbelline
(17), l-epibowdensine (18), l-epideacetylbowdensine (19), l-epidemethoxy-
bowdensine (20), josephinine (21), flexinine (22), crinamidine (23) and undulatine
(24) have been isolated from Brunsvigia (Table 2.1).
Crinine shows weak analgesic activity in mice and is a tachycardiac agent in dogs
[16]. All of the above alkaloids exhibit some analgesic activity and this is attributed
to their resemblance to morphine and codeine skeletons [28]. The above alkaloids,
however, are quite toxic.
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2.2 Results and Discussion
In a previous investigation of Brunsvigia radulosa only four alkaloids, brunsvigine
(5), galanthamine (6), lycorine (1) and crinamine (8), have been isolated [7].
Brunsvigia radulosa was thought to posses more alkaloids than reported and hence
further investigation was required. Ofparticular importance was the potent inhibitory
activity of Brunsvigia radulosa against the P-388 lymphocytic leukemia. This
investigation was carried out to isolate novel alkaloids that might manifest significant
bioactivity and thus be medicinally beneficial. The ethanol extract of the bulbs
yielded six alkaloids, lycorine (I), 1-0-acetyllycorine (11), crinine (IV), crinamine
(V), hamayne (VI) and anhydrolycorinium chloride (VII), after separation by column
chromatography over silica gel. Lycorine (I) was acetylated to yield 1,2-di-O-
acetyllycorine (Ill).
Four alkaloids which were not reported before from Brunsvigia radu/osa, are reported















Figure 2.6: Compounds isolated from Brultsvigia radulosa
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Figure 2.7: COMPOUND I: lycorine
Lycorine (I) was isolated as a white crystalline material. Lycorine has been isolated
previously from Brunsvigia radulosa [7]. Lycorine is the most widespread alkaloid of
the Amaryllidaceae [16]. It exhibits extensive bioactivity (see preceding chapter).
Spectra for lycorine are given on pages 153-157 in appendix A.
HRMS showed an intense molecular ion peak at m/z 287.1449, which corresponds to
the molecular fonnula CI6H17N04. Twin base peaks occur at m/z 227 (M-60) and m/z
226 (M-61). The only other fragment of reasonable intensity occurs at m/z 268 (M-
19). This peak is due to the loss of water as well as a hydrogen atom (scheme 2.1).
The ease of the loss of water from the molecular ion has been found to be greatly
dependent on the stereochemistry of the C-2 hydroxyl group i.e. a C-2a. hydroxyl
group is more easily lost than a C-2~ hydroxyl group [29]. Thus in the mass spectrum







Scheme 2.1: Mass fragmentation pattern of lycorine (I) [29]
The twin base peaks at m/z 227 (M-60) and m/z 226 (M-61) were shown to result from
the loss of carbon atoms C-I and C-2 and their substituents, by a reverse Diels Alder
fragmentation (scheme 2.2) [29]. This fragmentation pattern is common to all 3, 3a -








m/z 227 m/z 226
Scheme 2.2: Mass fragmentation pattern of lycorine (I) [29]
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The infra red spectrum showed a band at Vmax 3330 (0 - H stretching) indicative of
hydroxyl groups. Sharp bands were also observed at 1044 cm- l and 1004 cm-
l
(C - 0
stretching). Bands at 1505 cm- l and 1498 cm- l (aromatic C = C stretching) suggested
an aromatic ring. Bands observed at 1274 cm-l and 1241 cm-l (C - N stretching) are
characteristic for C - N bonds. The band at 945 cm-l (C - 0 - C stretching) is
indicative of the methylenedioxy group.
The lH NMR spectrum showed two singlets at OH 6.91 and OH 6.67, integrating to one
proton each, for the para-oriented aromatic protons. According to Ghosal's review, in
the lycorine type alkaloids, the H-ll signal always appears at a lower field than the
corresponding H-8 signal [30]. The H-ll proton being near in space to the C-ring,
experiences a diamagnetic shift from the unsaturation in that ring [30]. Hence, the
signal at OH 6.91 was assigned to H-ll and the signal at OH 6.67 was assigned to H-8.
The singlet at OH 5.94 integrates to two protons and was assigned to the two
methylenedioxy protons. The broad singlet observed in the olefinic region of the
spectrum, at OH 5.59, was assigned to H-3. The resonances at OH 4.48 and OH 4.20,
each integrating to one proton, were assigned to H-l and H-2 respectively. The two
benzylic protons, H-7a and H-7P, were observed resonating at OH 3.57 (d) and OH
4.15 (d) respectively. p-protons at position 5 and 7 are deshielded more than their a -
homologues due to the effect of the cis - lone pair of electrons of the nitrogen atom
[39,40]. The multiplet at OH 3.38 and the doublet doublet at 2.48 (J=17.52 Hz, 8.69
Hz) were assigned to H-5P and H-5a respectively and this was consistent with
literature. The resonance ascribed to H-11b was observed as a multiplet at OH 2.70
and the resonance attributed to H-llc appeared as a doublet at OH 2.93 (J=11.20 Hz).
The multiplet at OH 2.65 was assigned to the two H-4 protons left. All assignments
were consistent with literature [32]. Two dimensional spectra for lycorine could not
be obtained due to its relative insolubility in common organic solvents. Furthermore
lycorine is a relatively well known alkaloid and it is easily identified from its lH and
l3C NMR spectra.
35
Table 2.3: IH NMR data for compound I and literature data for lycorine
(J given in Hz in parentheses)
o IH NMR spectrum measured in CD30D, 300 MHz.
00 IH NMR spectrum measured in CD30D - CD3COOD (3: 1), 270 MHz.
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The 13C NMR data observed for compound I was consistent with that reported for
lycorine in the literature (table 2.4). Sixteen signals were observed in the 13C NMR
spectrum. Nine signals were observed in the low-field region (> 90 ppm) and these
corresponded to the aromatic carbons, the olefinic carbons and the methylene carbon
of the methylenedioxy group. The high-field region contained the seven signals
corresponding to the saturated carbon resonances of lycorine.
Table 2.4: BC NMR data for compound I and literature data for lycorine
o l3c NMR spectrum measured in CD30D, 75 MHz.
00 13CNM .R spectrum measured m DMSO-d6, 75.6 MHz.
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Figure 2.8: COMPOUND 11: 1-0-acetyllycorine
1-0-Acetyllycorine (11) was isolated as a white crystalline material. 1-0-
Acetyllycorine was identified on the basis of its physical and spectroscopic data
(table 2.5 and table 2.6). This is the first report of l-O-acetyllycorine in Brunsvigia
radulosa. Spectra for 1-0-acetyllycorine (11) are given on pages 158-164 in appendix
A.
A molecular ion peak at m/z 329.1272 was observed in the mass spectrum of 1-0-
acetyllycorine and this corresponded to a molecular formulae of C1sH19NOS. The
mass spectrum contained intense twin peaks at m/z 227 (M - 102) and m/z 226 (M -
103). These peaks were also observed in the spectrum of lycorine (I) and are
common to all 3,3a-unsaturated lycorine type alkaloids. As was the case for lycorine,
these peaks can be attributed to the loss of C-l and C-2, together with their
substituents (scheme 2.2). In addition to the different molecular ions present, the
mass spectrum of lycorine differs from that of 1-0-acetyllycorine (11), in that a peak
corresponding to the loss of water (scheme 2.1) is not observed in the latter
compound. This is consistent with the literature of acetyl derivatives of lycorine [29].
38
The infra red spectrum showed bands at Vmax 945 cm-I (C - 0 - C) indicating the
presence of the methylenedioxy group, 1241 cm-I (C -N stretching) indicating C - N
bonds, 1485 cm-I (aromatic C = C stretching) indicative of an aromatic ring, 1051
cm-1 and 1004 cm-I (C - 0 stretching), 1748 cm-I (C = 0 stretching) indicative of the
acetate group and the band at Vmax 3440 cm-I (0 - H stretching) confirming the
presence of an hydroxyl group.
Examination of the IH NMR spectrum showed a marked similarity to that of lycorine
(I). The two singlets at OH 6.67 (H-8) and OH 6.76 (H-ll) and the singlet at OH 5.94,
which integrated to two protons, indicated the presence of an unaltered ring A and
dioxolane ring system. In the same way, the appearance of the two doublets of an AB
system at OH 3.60 (J=14.28 Hz, a typical value for geminal coupling) and OH 4.16
(J=14.28 Hz) and the broad singlet of an olefinic proton at OH 5.58 were consist~nt
with the presence of lycorine - like Band C rings. Furthermore, the resonances' for
H-4 and H-5 were consistent with those of lycorine (I) with respect to both the
chemical shift and multiplicity.
The difference between the IH NMR spectrum of compound 11 and that of lycorine (I)
was that the former spectrum showed a methyl proton resonance at OH 1.93. In
addition to this, the broad singlet that appeared at OH 4.48 and attributed to H-l in
lycorine, now appeared at OH 5.73 in the 1H NMR spectrum of compound 11. This
was indicative of the hydroxyl group on C-l being acetylated.
The BC NMR spectrum of compound 11 showed eighteen signals. The low-field
region ( >90 ppm) contained the signals of the carbonyl group, the olefinic and
aromatic carbons as well as the carbon of the methylenedioxy group. Eight signals
corresponding to saturated carbon resonances were found in the high field region.
The IH and BC NMR resonances were assigned by comparison to literature data and
were confirmed by 2D NMR techniques (table 2.5 and 2.6)
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Table 2.5: IH NMR data for compound 11 and literature data for 1-0-
Acetyllycorine [31], (J given in Hz in parentheses)
® lH NMR spectrum measured in CD30D, 300 MHz.
®® lH NMR spectrum measured in CDCh, 270 MHz.
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Table 2.6: l3C NMR data for Compound 11 and literature data for 1-0-
acetyllycorine [31]
l3C NMR spectrum measured in CD30D, 75 MHz
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Figure 2.9: COMPOUND Ill: 1,2-di-O-acetyllycorine
Lycorine (I) was acetylated to yield compound Ill. Compound III was recrystallized
from EtzO - MeOH to give colourless platelets. The physical and spectral ( JR, IH
NMR, 13C NMR, MS) properties observed for compound Ill, were consistent with
those reported for 1,2-di-O-acetyllycorine [29,33]. Spectra for compound III are
given on pages 165-171 in appendix A.
The mass spectrum of 1,2-di-O-acetyllycorine (Ill), showed a molecular ion peak: at
m/z 371 (CZOHZIN06) and significant peaks at m/z 311, 252, 251, 250, 227, 226, 149,
97 and 43. The peaks at m/z 227 and 226 were in agreement with the fragmentation
scheme proposed for lycorine type alkaloids (scheme 2.2).
The infra red spectrum of compound III was similar to that of 1-0-acetyllycorine.
The IH and the BC NMR spectra of III were similar to those of 1-0-acetyllycorine
(11). The IH NMR spectrum showed an additional methyl resonance at ()H 2.12.
Furthermore, the H-2 signal in 11 appeared at ()H 4.19 (brs) but in III it appeared at ()H
5.29 (brs). This suggested that the C-2 hydroxy group had been acetylated. Thus the
acetylation of lycorine causes the two methine protons, H-l and H-2, to shift
downfield corresponding to ~8H 1.30 and ~8H 1.09 respectively. These findings are
consistent with literature [15].
42
Table 2.7: Comparison of IH NMR data for lycorine (I), 1-0-acetyllycorine (11)
and 1,2-di-O-acetyllycorine (Ill) (J given in Hz in parentheses)
IH NMR spectrum measured in CD30D, 300 MHz.
The acetylation of an allylic hydroxyl group may cause pcarbons to be shielded and y
carbons to be deshielded [1,34]. A comparison of 11 with Ill, shows that in III the C-
l (P) and C-3 (P) resonances have been shielded by ~oc 2.8 and ~oc 3.7 ppm
respectively. Furthermore C-3a and C-11b in Ill, the y carbons, have been deshielded
by ~oc 3.1 and ~oc 0.2 ppm respectively. This evidence confirms the acetylation of
the allylic hydroxyl group.
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Table 2.8: Comparison of l3C NMR data for lycorine (I), 1-0-acetyllycorine
(11) and 1,2-di-O-acetyllycorine (Ill)
® 13C NMR spectrum measured in CD30D, 75 MHz.
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Compound IV (C16H17N03) was recrystallized from MeOH to yield colourless
needles with a melting point of 207 - 208 0c. Compound IV responded to
Dragendorff reagent, was insoluble in dilute aqueous NaOH and gave a negative
FeC!) test. Spectra for compound IV are given on pages 172-179 in appendix A.
The base peak in the mass spectrum of compound IV corresponded to the molecular
ion (m/z 271). The mass spectrum of compound IV displayed minor peaks
corresponding to fragments of m/z 256 (M - 15), 254 (M - 17), 242 (M - 29) and 240
(M - 31). The first ion of appreciable abundance in the spectrum, occurred at m/z
228. High resolution mass spectrometry has shown this peak to be of the composition
65% C14H1203+ and 35% C14H14N02+ (table 2.9) [35].




















Scheme 2.3: A suggested mechanism for the formation of the major fragment at
m/z 228 [35]
Fragmentation of the molecular ion (IVa) of crinine to yield IVb, followed by
elimination of a neutral amine fragment would generate the species IVc, m/z 228.
Scheme 2.3 provides a possible mechanism which accounts for the origin of the major
component of mass 228 in the spectrum of crinine.
A mechanism for the formation of the minor fragment at m/z 228 (C14H14N02+) in the
mass spectrum of crinine involves the formation of the species IVd, from the
molecular ion Va. The subsequent elimination of ·CH2CHO would then produce the
















Scheme 2.4: A suggested mechanism for the formation of the minor fragment at
m/z 228 [35]
A prominent ion of mass 199 (M - 272) in the mass spectrum of crinine corresponds
to CI3Hl102+ (table 2.9). The origin of this ion is considered to be the expulsion ofa
formyl radical from the species IVc to yield IVf (m/z 199) [35]. Loss of acetylene









Scheme 2.5: Mechanism for the formation of fragments at m/z 173 and 172 [35]
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Fragment IVg, then loses a hydrogen atom to yield the oxygenated naphthalene ion
(IVh). All three schemes provide plausible pathways which are consistent with the
results ofhigh resolution mass spectrometry (table 2.8) [35].
Compound IV displayed DV absorptions at A 291 urn and A 230 urn in methanol.
This is consistent with the DV spectra of 5,1Ob-ethanophenanthridine type alkaloids
having a methylenedioxy aryl chromophore and an isolated double bond [30].
~
The infra red spectrum exhibited absorption frequencies at Vmax 3350 cm-
l (0 - H
stretching) ~nd 1036 cm-! (C - 0 stretching). Peaks were also observed at Vmax 2928 v"
cm-! (aliphatic C - H stretching), 1496 cm-! (aromatic C = C stretching ), 1238 cm-!
(C - N stretching) and a peak at Vmax 941 cm-! (C - 0 - C stretching) which is
indicative of a methylenedioxy group.
The lH and l3C NMR resonances were in agreement with previously published data
[36]. 2-D NMR techniques (COSY and HETCOR) were used for the assignment of
the !H NMR and part of the l3C NMR spectra.
The !H NMR spectra of compound IV exhibited methylenedioxy proton doublets and
aromatic proton singlets in the downfield region. The superimposed methylenedioxy
resonances were located at 8H 5.89. The chemical shifts of the aromatic hydrogens at
C-7 and C-I0 gave typical signals of aryl hydrogens adjacent to oxygen functions
[37]. The singlet resonances at 8H 6.83 and 8H 6.47 were thus assigned to the
aromatic H-I0 and H-7 protons respectively. These assignments were based on
Haugwitz's proposal that the H-I0 proton signal occurs as a sharp singlet and is
located at a consistently lower field than the H-7 proton signal [37]. Furthermore,
Haugwitz et al. found that the latter signalwas slightly shorter and broader than the
former, indicative of weak splitting, presumably from the coupling with one or both
of the benzylic hydrogen atoms [37,38].
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The benzylic protons (H-6a and H-6P) were clearly differentiated as an AB-system
with a geminal coupling constant of 16.9 Hz. This coupling was clearly visible in the
COSY spectrum. The doublets, at bH 3.81 and bH 4.43, were assigned to H-6~ and H-
6a respectively. H-6a was assigned to the resonance at the lower field due to its cis-
relation with the nitrogen lone pair [39,40].
H-l, H-2 and H-3 of compound IV gave rise to an ABX pattern in the IH NMR
spectrum. The chemical shifts and the coupling constants can be determined by direct
measurement and first order considerations [37]. The olefinic spectral region showed
two resonances. The doublet located at the lower end of the olefinic region is a one -
proton doublet (J1,z = 10.0 Hz) which was assigned to H-l. The remaining doublet
doublet resulting from H-2 coupling with H-1 (Jl,Z = 10.0 Hz) and with H-3 (JZ,3 = 5.4
Hz). The resonance for H-3 occurred as a multiplet at bH 4.35.
The magnitude of the coupling constants between each olefinic proton (H-l and H-2)
and H-3 gives information about the configuration of the C-3 substituent. The
hydrogen atoms, H-I and H-2 have a dihedral angle of approximately 0° (from
molecular models). They split each other into doublets of coupling constant 10 Hz. If
the oxygen substituent at C-3 and the 5,10b ethane bridge are on the same side of the
molecule, then the dihedral angle between H-2 and H-3 is approximately 90° and the
H-2 resonance remains as a doublet of 10Hz. However, if the oxygen substituent and
the ethane bridge are on opposite sides, then the dihedral angle between H-2 and H-3
is approximately 30° and the H-2 doublet is further split into a double doublet ofJl,Z =
10 Hz and JZ,3 = 5 Hz. Thus a H-2 resonance which is split into a doublet of 10 Hz
indicates a cis relationship between the oxygen substituent at C-3 and the 5,lOb
ethane bridge while a H-2 resonance split into a doublet doublet of 10 Hz and 5 Hz
suggests a trans relationship [1,36,37,40].
The subsequent inspection of the IH NMR spectrum of compound IV revealed a trans
orientation between the ethane bridge and the oxygen substituent on C-3 as the H-2
resonance is split into a doublet doublet (JI,2 = 10.0 Hz, JZ,3 = 5.4 Hz).
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The location of the aliphatic hydroxyl group is derived from the splitting pattern of
the H-2 signal group. Only in the case of a hydroxyl group being substituted in C-3,
which is biosynthetically facile, can the observed doublet of doublets be explained.
H-2 couples with H-3 and with H-1 to yield the observed multiplicity.
The C-4, C-11 and C-12 methylene protons and the C-4a methine proton were
completely assigned by means of 2-D COSY and HETCOR experiments. H-3 is seen
to be coupled to H-l, H-2, H-4a and H-4P in the COSY spectrum. Since H-l and H-2
have been assigned (olefinic resonances), the remaining two resonances (DH 1.74 and
1.98) can be assigned to the H-4 protons. These resonances also showed coupling in
the HETCOR spectrum to a methylene carbon resonance. The large coupling (J =
13.8 Hz), which is due to their trans diaxial configuration allowed the doublet of
doublets at DH 3.38 and the triplet of doublets at OH 1.74 to be assigned to H-4a and H-
4p, respectively. The doublet at OH 1.98 was thus assigned to H-4a.
Four resonances, two for H-11 and H-12 each remained. Of these, the two lower field
resonances were assigned to H-12 because of their proximity to the ring nitrogen
atom. The H-12 protons were observed as a broad doublet at DH 3.30 Hz and a
mu1tiplet at DH 2.93. The low field signal was attributed to H-12exo because of its co-
planarity with the nitrogen lone pair [39,40]. The remaining two resonances were
assigned to H-11 endo and H=ll exo by comparison with the literature [36].
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Table 2.10: IH NMR data for compound IV and literature data for crinine [36]
(J given in Hz in parentheses)
IH NMR spectrum measured in CDCb, 300 MHz.
Analysis of the 13C NMR and DEPT spectra revealed the presence of five methylene
carbons (oc 100.8, 61.5, 53.1, 43.6, 32.3), six methine resonances (oc 13.7, 128.0,
106.9, 102.9, 63.3, 62.9) and five quaternary carbon resonances. The COSY, DEPT
and HETCOR spectra were used to fully assign all protonated carbons. The
resonance at Oc 44.3 was assigned to the aliphatic quaternary carbon. The remaining
four aromatic quaternary carbon resonances (C-6a, C-8, C-9, C-I0a) were assigned by
comparison to literature [32].
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Table 2.11: 13C NMR data for Compound IV and literature data for
crinine [32]
® 13C NMRspectrum measured in CDC13, 75 MHz.
®® 13C .NMR spectrum measured III CDCh, 50 MHz.
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Figure 2.11: COMPOUND V: crinamine and COMPOUND VI: hamayne
Compound V was isolated as white crystalline material. Compound V was found to
be the major alkaloid in Brunsvigia radulosa. The physical and spectral data of V
were comparable with those of crinamine. Crinamine has been found previously in
Brunsvigia radulosa [7], Brunsvigia orientalis [39], Brunsvigia josephinae [1] and
many other crinum species [16]. Spectra for compound V are given on pages 180-189
in appendix A.
The mass spectrum of compound V showed a very weak molecular ion peak « 1%) at
m/z 301, which excludes the haemanthamine series. Its fragmentation pattern was
consistent with crinamine and is characterized by a cis configuration between the C-3
substituent group and the 5,10b-ethano bridge, together with a substituent in the
bridge and a double bond in ring C [43]. The presence of a hydroxyl group at C-ll
governs almost entirely the fragmentation pattern of this kind of alkaloid due to the
ability ofthe hydroxy proton to rearrange [43].
The weak molecular ion peak of V can be attributed to its facile loss of methanol
(figure 2.12). The loss of methanol to give a peak at m/z 269 (M-32), is highly
favoured when both the ethane bridge and the methoxyl group at the C-3 position are
on the same side of the molecule [39]. The driving force for the elimination of
methanol in crinamine is the release of steric strain originating from the proximity of






Va, m/z 301 Vb, m/z2~9
Figure 2.12: Mechanism for the formation of the base peak in compound V

















Scheme 2.6: The mass spectrometeric fragmentation pattern of compound V [35]
The species Va undergoes an a - cleavage to yield Vc. The subsequent loss of CR20
from Vc results in the formation of Vd. Vd then losses a methoxyl radical, resulting
in the species Ye, which is the m/z 240 fragment observed in the mass spectrum.
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High resolution mass spectrometry has also established the composition of the peak at
m/z 211 in the spectrum of crinamine to be C14Hl102+ [35]. The origin of this species
can be shown to result from the loss of the neutral fragment NH=CH2 from the ion Ve
(m/z 240) resulting in the formation ofVj (m/z 211). Vj can lose 30 mass units by the
ejection of formaldehyde from the methylenedioxy group. The product of this













Scheme 2.7: The mass spectometeric fragmentation pattern of compound V [35]
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The DV spectra of Amaryllidaceae alkaloids, taken in a neutral solvent (e.g. methanol
or ethanol), provides information regarding the type of the ring system (e.g. lycorine/
lycorenine/5,1Ob-ethanophenathridine/pyrrolophenanthridone) [30]. The DV
spectrum of compound V was consistent with that of a 5,1Ob-ethanophenathridine
type alkaloid. Alkaloids with a methylenedioxy aryl chromophore and an isolated
double bond, exhibit a maximum near 1-,240 nm and another maximum around 1-,280-
290 nm [30]. Compound V exhibited a absorbance around I-,max 291.2 run and a
shoulder at Amax 240.5 nm in methanol.
The infra red spectrum of compound V was consistent with that of crinamine
[26]. The infra red spectrum showed bands at Vmax 3400 cm-
1 (0 - H stretching) and
1044 cm-1 (C - 0 stretching), 1630 cm-1 and 1492 cm-1 (aromatic C = C stretching)
indicating the presence of an aromatic ring, 1241 cm-1 (C - N stretching) indicative
of carbon nitrogen bonds and 945 cm-1 (C - 0 - C stretching), suggestive of the
presence of a methylenedioxy group.
The IH NMR spectrum of compound V, recorded in deuterated methanol, exhibited
three singlets at ()H 6.89, 6.56 and 5.91. These resonances were assigned to the
aromatic protons, H-I0 and H-7, and to the protons of the methylenedioxy group
respectively. The assignment of these resonances was consistent with literature
[30,37]. The two olefinic resonances of compound V were observed as a doublet at
()H 6.11 (J = 10.32 Hz) and a doublet of doublets at ()H 6.31 (J = 2.13, 10.44 Hz).
These resonances were assigned to H-2 and H-l respectively. The NOESY spectrum
showed a NOESY correlation between H-l and H-IO, confirming their assignments.
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The COSy spectrum showed strong coupling between H-l and H-2. Furthermore, H-
I could be seen coupling to a resonance at OH 4.10 Hz. This multiplet was assigned to
H-3. The NOESY spectrum showed a NOESY correlation between H-2 and H-3, thus
confIrming their assignments. The absence of coupling between H-2 and H-3 (the
dihedral angle between H-2 and H-3 is approximately 90°), an allylic coupling
between the vinylic H-l and the allylic H-3 and the NOESY correlation between H-3
and H-4a, were indicative of a cis - relationship between the C-3 substituent and the
5,lOb ethane bridge. This was confirmed by the mass spectrum of V, which showed
the facile loss of methanol, which is typical for compounds having both the ethane
bridge and the methoxyl group, at the C-3 position, on the same side of the molecule
[39].
The NOESY spectrum showed a correlation between the H-3 proton and the protons
of the methoxyl group. This allowed the methoxyl group to be assigned to C-3 as
opposed to C-l1. The COSY spectrum showed H-3 additionally coupling to the two
protons on C-4, at OH 2.08 and OH 2.15. These resonances were ascribed to H-4a. and
H-4B respectively. The HETCOR spectrum confirmed that these protons were
geminal. The NOESY correlation between H-4a. and the methoxyl group protons
confIrmed the stereochemical assignments of the H-4 protons. The COSY spectrum
also showed the H-4 protons coupling to a resonance at OH 3.28. This signal was
assigned to H-4a. NOESY correlations between the two H-4 protons and H-3, as well
as the NOESY correlation between H-4a and the two H-4 protons suggested that their
assignments were correct. The H-6 protons appeared as a pair of doublets at OH 3.73
and OH 4.33. These resonances were seen to be coupled in the COSY spectrum. The
coupling constant of 16 Hz is typical for such geminal protons. The HETCOR
spectrum confIrmed that the protons were geminal. The lower fIeld resonance was
assigned to H-6B due to its cis - relation with the nitrogen lone pair [39,40]. The
NOESY interaction between H-6B and H-4a confirmed their assignments.
The doublet of doublets at OH 4.00 was assigned to H-ll endo. The HETCOR spectrum
showed a correlation between this assigned resonance and a methine carbon at oe
81.0. The H-ll proton was assigned to the endo-position due to its NOESY
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interaction with the H-10 proton. The deshielding effect on H-1l in relation to the
reported data for alkaloids with no bridge substituent in this series [39,41], and the
NOESY interaction between H-IO and H-ll were consistent with a C-ll hydroxyl
substituent at the exo-position. The remaining resonances at bH 3.50 and bH 3.23 were
assigned to H-12exo and H-12endo respectively. The HETCOR spectrum showed a
correlation between these resonances and a methyl carbon at be 63.6. The strong
NOESY interaction between H-llendo and H-12endo suggested that their assignments
were correct.
Table 2.12: IH NMR data for compound V and literature data for
crinamine [26] (J given in Hz in parenthesis)
® IH NMR spectrum recorded in CD30D, 300 MHz.
00 IH NMR spectrum recorded in CDCl), 300 MHz.
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Compound VI was isolated as white crystalline material with a melting point of 180
CC. Its physical and spectral properties were consistent with those of hamayne.
Hamayne has been previously isolated from Brunsvigiajosephinae [43]. Spectra for
compound VI are given on pages 190-197 in appendix A.
The mass spectrum of compound VI showed a weak molecular ion peak at m/z 287
which corresponded to the fOffimla Cl6H17N04. The base peak of compound VI
occurred at m/z 269 (M+ - 18) and was attributed to the loss of water. The mass
spectrum of compound VI closely matched that of crinamine (V). Comparison of the
molecular ion peaks suggested that compound VI was methylated. The peaks at m/z
. 240, 211 'and 181 were accounted for in the same way as those of crinamine (V)
(scheme 2.7 and 2.8).
The infra red spectrum of VI showed bands at Ymax 3400 cm-
l (0 - H stretching),
1044 and 1037 cm-l (C - 0 stretching), 1478 cm-l (aromatic C = C stretching), 1235
cm-l (C - N stretching) and 945 cm-! (C - 0 - C stretching), indicative of the
methylenedioxy group.
The lH NMR spectrum of compound V was similar to that of crinamine except for the
absence of a methoxyl group proton resonance. The spectrum recorded in CD30D,
exhibited three singlets at ()H 6.60, 6.92 and 5.93, for the aromatic protons, H-I0 and
H-7, and for the protons of the methylenedioxy group respectively. The olefinic
protons, H-l and H-2, were observed as a doublet of doublets at ()H 6.25 and a doublet
at 8H 6.09 respectively. H-l is seen to be coupled with H-2 and H-3 (J1.2 = 10.38, J l.3
= 2.26). H-2 is seen to be coupled only with H-l (Ju = 10.38), as the dihedral angle
between H-2 and H-3 is approximately 90° (see page 49). The multiplicities ofH-1
and H-2 were in agreement with the cis - relationship between the C-3 substituent
and the 5,lOb - ethano bridge [43]. Two doublets for the AB system of the C-6
protons were observed at ()H 3.95 and ()H 4.47. These signals were assigned to H-6a
and to H-6P respectively on the basis of their proximity to the nitrogen lone pair [39].
Weak coupling between H-l and H-3 observed in the COSY spectrum, allowed the
latter proton to be assigned. H-3 was observed resonating at ()H 4.37 as a multiplet.
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The H-3 resonance also exhibited strong coupling with the multiplets at OH 2.11and OH
2.20. These resonances were attributed to the protons on C-4. The two resonances
also correlated with the C-4 resonance at oe 33.5 in the HETCOR spectrum, thus
confirming their assignments. The H-4 resonances were also observed to be coupled
to the H-4a resonance in the COSY spectnllTI. The doublet of doublets at OH 3.48 (J =
13.62, 4.40 Hz) was accordingly assigned to H-4a. The H-l1 proton resonance
appeared as a one proton multiplet at OH 4.05. This resonance was also seen to be
coupled to the resonances at 01-1 3.38 and OH 3.66. From the HETCOR spectrum it
could be inferred that these resonances were for geminal protons. The doublet of
doublets at OH 3.66 was assigned to H-12endo on the basis of its proximity to the
nitrogen lone pair [39].
Table 2.13: IH NMR data for compound VI and literature data for
hamayne [43] (J given in Hz in parenthesis)
I8l IH NMR spectrum recorded in CD30D, 300 MHz.
I8lI8l IH NMR spectrum recorded in CDCh, 200 MHz.
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Table 2.14: l3C NMR data of compound V and compound VI and literature
data for crinamine and hamayne
100.87
@ 13C NMR spectrum recorded in CD30D, 75 MHz.
@@ 13C NMR spectrum recorded in CDCh, 50 MHz.
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2.2.6 The structural elucidation of compound VII
---'5
VII
Figure. 2.13: COMPOUND VII: anhydrolycorinium chloride
Compound VII was isolated as pale yellow needles (24 mg). Its solubility behaviour,
high decomposition point (>280 QC) and colour were consistent with a quaternary
ammonium halide type of system [45]. In addition to this, an aqueous neutral solution
of compound VII gave a strong test for chloride ions with AgN03. Spectral data,
particularly DV and the I H NMR spectrum obtained for the chloride salt, were
consistent with a phenanthridinium structure. Spectra for compound VII are given on
pages 198-208 in appendix A.
The physical and spectral (JR, DV, IH NMR, 13C NMR and MS) properties observed
for compound VII were consistent with those reported for anhydrolycorinium
chloride [45,46,47]. The non-chiral anhydrolycorinium chloride was first isolated
from Amaryllis belladonna and its structure elucidated by Pettit et al. in 1984 [45].
Compound VII responded to Dragendorff reagent and a blue flourescence could be
seen when a TLC plate, containing VII, was exposed to DV light.
Compound VII exhibited three high intensity DV maxima at A258, 268, 279 urn and
a maximum at A 340 urn was also observed in methanol. The DV maxima of
compound VII were consistent with those of anhydrolycorinium chloride [45,47].
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The low resolution mass spectrum of VII did not show a molecular ion peak. The
anhydrolycorinium cation (C I6H12NO/) requires 250.0836 mass units. The base peak
in the mass spectrum of VII occurred at m/z 248 and could be attributed to the loss of
two hydrogen atoms and the subsequent aromatization of the five membered nitrogen
ring. The minor peak at m/z 218 is due to the loss of formaldehyde from the
dioxolane ring (scheme 2.8). No mass spectrometric details were given in Pettit's
paper on anhydrolycorinium chloride [45].
The infra red spectrum of compound VII was consistent with that of
anhydrolycorinium chloride. Peaks were observed at Ymax 3402 (due to water of
crystallization), 1486, 1271, 1039 and 917 cm-1 (C - 0 - C stretching).
The lH NMR spectrum of compound VII suggested a lycorine type structure having
some structural modifications on the Band C rings. The lH NMR spectrum showed a
pair of tliplets corresponding to two protons each at OH 3.85 and OH 5.27. The
resonance at OH 5.27 was assigned to H-5 due to its proximity to the nitrogen atom.
The signal at OH 3.85 was thus assigned to H-4. Vicinal coupling between the two
triplets was observed in the COSY spectrum. In addition to this, coupling between H-
5 and H-7 is observed in the COSY spectrum, thereby confirming the assignments of
the methylene protons. The most downfield resonance (OH 9.64) in the lH NMR
spectrum was assigned to the iminic proton H-7. The downfield chemical shift of H-7
is due to the nitrogen quatemization or iminium salt effect [48,49].
The NOESY spectrum showed a correlation between H-7 and a sharp singlet at OH
7.79 (figure 2.14). This singlet was assigned to H-8. The other sharp singlet in the
spectrum at OH 8.32 was assigned to H-ll. These assignments are consistent with
Ghosal's proposal for the para-oriented protons of ring A [30]. The doublet at OH
8.54 was attributed to H-l. The observed multiplicity, together with its spatial
proximity to H-ll, as observed in the NOESY spectrum, confirmed this assignment.
The resonance assigned to H-l can be seen to be coupled to the H-2 resonance in the
COSY spectrum. The correlated peak at bH 7.94 was accordingly assigned to H-2.
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The multiplicity of H-2 (triplet) confinns its assignment. The peak at OH 7.86 was
assigned to H-3. H-3 can be seen to be coupled to H-2 in the COSY spectrum. The
NOESY correlation between H-3 and H-4 confinned their assignments (fig. 2.14).
NOESY correlations were also observed between the two H-4 and the two H-5
protons. Finally, the intense singlet, integrating for two protons, at OH 6.39 was
assigned to the geminal H-12 protons of the methylenedioxy group. This singlet was




FIGURE 2.14: The NOESY interactions observed for anhydrolycorinium
chloride
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Table 2.15: IH NMR data for compound VII and literature data for
anhydrolycorinium chloride (J given in Hz in parentheses)
IH NMR measured in CD30D, 400 MHz.
IH NMR measured in D20, 100 MHz.
IH NMR measured in D20, 500 MHz.
The l3C NMR spectrum of compound VII contained sixteen carbon signals. Two of
the carbon signals corresponding to C-3a and C-llc overlapped each other. ADEPT
spectrum revealed the presence of seven quartenary carbons, six methine carbons and
three methylene carbons. The l3C NMR spectrum of compound VII was consistent
with that of literature [45,46,47]. The literature for anhydrolycorinium chloride
contains either unassigned or tentative assigmnents with regard to the l3C NMR data
[45,47]. Several 13C NMR spectral assigmnents corresponding to the pair C-l/C-2
and also the quartemary carbons, have been changed in accordance with HMQC and
HMBC data. The unequivocal carbon assigm11ents are given in table 2.16.
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Table 2.16: 13C NMR and HMBC data for compound VII
c
c
BC NMR spectrum measured in CD30D, 100 MHz.
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2.3 CONCLUSION
The bulbs of Brunsvigia radulosa were investigated. The ethanol extract of the bulbs
yielded six alkaloids, lycorine (I), 1-0-acetyllycorine (11), crinine (IV), crinamine
(V), hamayne (VI) and anhydrolycorinium chloride (VII), after separation by column
chromatography over silica gel. Lycorine (I) was acetylated to yield 1,2-di-
acetyllycorine (Ill). Compounds n, IV, VI and VII have not been isolated
previously from Brunsvigia radulosa.
Lycorine (I) is an ubiquitous Amaryllidaceae alkaloid with significant bioactivity. Its
biological activities include the inhibition of growth and cell division in higher plants
and algae [13], inhibition of cyanide-resistant respiration [13,14], inhibition of amino
acid biosynthesis in vivo, as well as being active against RNA and DNA viruses [16-
19]. Crinine (IV) shows weak analgesic activity in mice and is a tachycardiac agent
in dogs [16]. Crinamine (V), is a powerful transient hypotensive agent in dogs. It
shows respiratory depressant activity [16,19]. Crinamine has also shown strong
cytotoxic and moderate antimalm1al activity [26].
In 1980, Charlson, showed that an extract of Brunsvigia radulosa increases the life
span ofP-388 leukaemic mice [10]. Sixty-four to sixty-nine percent life extension has
been reported [10,11]. In 1984, Pettit et al. isolated anhydrolycorinium chloride (VII)
from Amaryllis belladonna and showed it to be a potent antineoplastic agent with
strong inhibitory activity against murine P-388 lymphocytic leukemia [45]. The work
presented here suggests that anhydrolycorinium chloride (VII) could be the principal
antineoplastic component in Brunsvigia radulosa.
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2.4 Foreword to experimental
Nuclear magnetic resonance spectroscopy (NMR)
NMR spectrometry was recorded using a 300 MHz Varian Gemini spectrometer and a
Varian Unity Inova 400 Mhz spectrometer. The spectra were obtained using the
solvents deuterated methanol or deuterated chloroform. Each spectrum was
referenced against the central line of the deuteriochloroform signal at Cc 77.0, the
deuteriochloroform singlet at OH 7.24 ppm, the deuteriomethanol signal at Cc 49.0
ppm or the deuteriomethanol signal at OH 3.34 ppm.
Infra red spectroscopy (IR)
Infra red spectra were recorded using a Nicolet Impact 400 D spectrometer which was
calibrated against an air background. Either KBr disks or a NaCI window was used.
Melting points
Melting points were determined on a Kofler micro-hot stage melting point apparatus
and are uncorrected.
Optical rotations
Optical rotations were measured at room temperature in methanol or chloroform using
an Optical Activity AA-5 Polarimeter together with a series A2 stainless steel (4 x
200 run) unjacketed flow tube.
Mass spectroscopy
GC/MS spectra were recorded using either a Finnigan 1020 GCIMS spectrometer at
the Cape Technikon or an Agilent 6890 GC system with a 5973N Mass Selective
instrument at the University of Natal - Durban.
Ultraviolet absorption spectrometry
A Varian DMS 300 DV-visible spectrometer was used to obtain DV spectra.
Methanol was used as the solvent in all cases.
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Thin layer chromatography (TLC)
TLC was used to monitor the column chromatographic process using silica gel (0.2
mm thick) on aluminium backed plates (Merck Art.5554) which contained a
fluorescent indicator (F254). Plates were first analyzed under DV light and then
developed either with p-anisaldehyde spray reagent or freshly prepared Dragendorff
reagent. The p-anisaldehyde reagent was made up by mixing p-anisaldehyde,
concentrated sulphuric acid and methanol in the ratio 1:2:97. TLC plates were
developed with an heat gun. Dragendorff reagent was prepared by dissolving bismuth
(Ill) nitrate (1.7 g) and tartaric acid (20 g) in 80 ml of water to form solution A.
Potassium iodide (16 g) was dissolved in 40 ml water to form solution B. Equal
potions of solution A and B were mixed to form a stock solution which was stored in
the freezer. Shortly before use, a solution of tartaric acid (10 g) in 50 ml ofwater was
added to 10 ml of the stock solution. TLC plates with alkaloids present on them,
showed a dark orange colour when sprayed with Dragendorff reagent.
Acetylation
Lycorine (I), was acetylated. Lycorine (20 mg) was placed in a round bottom flask
with pyridine (1 cm3) and acetic anhydride (1 cm3). The flask was heated on a steam
bath for 10 minutes and then left at room temperature for approximately 48 hours.
Thereafter, excess acetic anhydride was removed by the addition of methanol (3 x 10
ml). This was followed by the removal of pyridine by adding toluene (3 x 10 ml).
After each addition, the solvent was evaporated off on the Rotavapor. Traces of
toluene was then removed by the addition of excess methanol. The sample was then
spotted on a TLC plate to test for the completion of the reaction.
Column Chromatography
Different size columns ranging from 1-3 cm in diameter were used in the crude
isolation procedure. Final purifications were carried out on an open, 0.75 cm
diameter pasteur pipette column. Merck 9385 silica gel was used as the solid phase
and elution was allowed to proceed by gravity. Solvents used in the chromatographic
process included hexane, methylene chloride, ethyl acetate and methanol.
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2.5 Experimental
Brunsvigia radulosa Herb. was obtained from Buffelskloof, Mpumalanga and
identified by Dr N. Crouch. A voucher specimen (Crouch 799) was deposited at the
Natal Herbarium. The leaves were removed and the dried bulbs (850 g) were finely
cut and extracted with 99% ethanol on a Labcon shaker for 96 hours. The extract was
evaporated under reduced pressure. The viscous extract was dissolved in water
(lOOml) and acidified to pH 4. Neutral material was removed with ether and
discarded. The acid solution was then extracted with chloroform, to provide extract
A. Basifying the solution to pH 8-9 and then extracting it with chloroform, gave
extract B. Finally, chlorofonn - methanol Cl: 1) extraction of the basic solution gave
extract C. TLC analysis suggested that all three extracts were similar. Thus A, B and
C (3.2 g) were combined and subjected to column chromatography.
Chromatographic separation of the combined extracts using a methylene chloride -
methanol step gradient (19:1, 18:2, 16:4, 12:8, 10:10,8:12,4:16,0:20) as the eluant
and collecting approximately 30 x 35 ml fractions for each step, gave lycorine (I),
which crystallized out of fractions 53-61, 1-0-acetyllycorine (11), present in fractions
22-27, crinine (IV), present in fractions 14-17, crinamine (V), found in fractions 34-
40, hamayne (VI), present in fractions 49-54 and anhydrolycorinium chloride (VII),
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Scheme 2.8: Extraction of Brul1svigia radulosa
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2.5.1 PHYSICAL DATA FOR COMPOUND I
NAME: lycorine
Yield: 72 rng
Melting point: 248 °C (lit. 250 °C [26])
Optical rotation: [a]o = -63 0 (c=1.5, EtOH); lit = -620 (c=O.l, EtOH) [5]
UV: Amax (MeOH), (log E), 210 (4.22), 237 (3.43), 292 (3.43)
Mass: [M+] at 111/Z 287.1156, CI6H17N04 requires 287.1156.
EIMS: 111/Z (reI. int.): 287 (57.34) [M+], 286 (37.36), [~ - H],
270 (l2.35) [M+ - OH], 269 (11.07) [M+ - H20], 268 (31.44)
[M+ - H20 - HJ, 250 (23.19), 227 (80.82) [M+ - CHOHCHOH],
226 (100.00) [M+ - CHOHCHOH - H], 147 (7.78), 111 (8.01)
Infra red: Vmax (ern-I): 3330, 3410 (0 - H stretching), 1505, 1498, 1274,
1241, 1044, 1004,945 (C - 0 - C stretching)
IH NMR: (CD30D): 2.48 (lH, dd, H-5, J = 17.52, 8.69), 2.65 (2H, rn, H-4), 2.70
(1H, 111, H-11b), 2.93 (1H, d, H-11c, J= 11.20),3.38 (lH,
rn, H-5), 3.57 (lH, d, H-7a, J = 14.22),4.15 (lH, d, H-7~, J
= 14.22),4.20 (lH, brs, H-2), 4.48 (lH, s, H-1), 5.59 (lH, brs,
H-3), 5.94 (2H, s, OCfuO), 6.67 (lH, s, H-8), 6.91 (lH, s, R-
11)
l3e NMR: (CD30D): 73.1 (CH, C-l), 71.9 (CH, C-2), 119.1 (CH, C-3), 143.6 (C, C-
3a), 29.2 (CH2, C-4), 54.5 (CH2, C-5), 57.5 (CH2, C-7), 130.4
(C, C-7a), 108.2 (CH, C-8), 148.2 (C, C-9), 147.7 (C, C-10),
106.0 (CH, C-l1), 129.7 (C, C-lla), 41.3 (CH, C-llb), 62.5
(CH, C-l1c), 102.2 (CH2, OCH20)
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2.5.2 PHYSICAL DATA FOR COMPOUND 11
NAME: 1-0-Acetyllycorine
Yield: 22mg
Melting point: 217°C (lit. 217-219 °C [5])
Optical rotation: [a]D = -88° (c=0.5, MeOH); lit = -106° (c=0.5, CHC!)) [5]
Mass: [M+] at m/z 329.1272, ClsH19NOs requires 329.1263
ElMS: m/z (reI. int.): 329 (61.4) [M+], 315 (38.24), 270
(13.39) [M+ - CH3COO], 269 (14.88) [M+ - CH3COOH], 268
(14.31) [M+ - CH3COOH - H], 254 (34.02) 252 (18.47) [M+ -
CH3COOH - OH], 250 (25.24), [M+ - CH3COOH - H20 - H],
228 (38.73), 227 (83.63) [M+ - CHOC(0)CH3 - CHOH], 226
(100) [M+ - CHOC(0)CH3 - CHOH - H], 149 (29.09), 43
(35.61)
Infra red: Vlllax (cm-
1
): 3440, (0 - H stretching), 1748, (C = 0 stretching),
1485,1241,1051,1004,945 (C - 0 - C stretching)
IH NMR: (CD30D): 2.51 (lH, dd, H-5, J = 17.6, 8.8), 2.68 (2H, m, H-4), 2.90
(lH, brs, H-llb), 2.90 (lH, brs, H-llc), 3.33 (1H, rn, H-5),
3.61 (lH, d, H-7a, J = 14.3), 4.17 (lH, d, H-7~, J = 14.3),
4.19 (lH, brs, H-2), 5.73 (lH, s, H-1), 5.58 (lH, brs, H-3),
5.94 (2H, s, OCfuO), 6.67 (lH, s, H-8), 6.76 (1H, s, H-11),
1.93 (3H, s, OCOCH3)
13C NMR: (CD30D): 73.4 (CH, C-1), 70.3 (CH, C-2), 119.0 (CH, C-3), 143.8 (C, C-
3a), 29.3 (CH2, C-4), 54.6 (CH2, C-5), 57.6 (CH2, C-7), 130.4
(C, C-7a), 108.4 (CH, C-8), 148.1 (C, C-9), 147.9 (C, C-10),
105.7 (CH, C-ll), 128.3 (C, C-lla), 40.1 (CH, C-llb), 62.9
(CH, C-llc), 102.4 (CH2, OCH20), 20.8 (CH3, OCOCH3),
172.2 (C, OCOCH3)
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2.5.3 PHYSICAL DATA FOR COMPOUND III
NAME: 1,2-di-O-acetyllycorine
Melting point: 205°C (lit. 208-210 °c [5])
Optical rotation: [a)D = -61 0 (c=1.0, MeOH); lit = -220 (c=0.9, CHC!)) [16)
Mass: [M+) at m/z 371.1360, CZOHZIN06 requires 371.1368
ElMS: m/z (reI. int.): 371 (20.37) [M+), 311 (12.24) [M+ -
CH3COOH), 252 (100) [M+ - CH3COOH - CH3COO), 251
(14.02) [M+ - 2XCH3COOH), 250 (46.41) [M+ - 2XCH3COOH
- H), 227 (18.24) [M+ - 2XCHOC(O)CH3), 226 (31.17) [~ -
2XCHOC(O)CH3- H), 149 (5.99),97 (9.56),43 (18.24)
Infra red: V max (cm-I): 1742, (C = 0 stretching), 1492 (aromatic C=C
stretching), 1248 (C - N stretching), 1044, 1004, 945 (C - 0 -
C stretching)
IH NMR: (CD30D): 1.95 (3H, s, OCOCH3-1), 2.12 (3H, s, OCOCH3-2), 2.52 (lH,
dd, H-5, J = 17.70, 8.90), 2.71 (2H, m, H-4), 2.91 (2H, s, H-
llb, H-llc), 3.40 (lH, m, H-5), 3.59 (1H, d, H-7a, J= 14,29),
5.29 (lH, brs, H-2), 5.56 (lH, brs, H-3), 5.78 (lH, s, H-1), 5.94
(2H, s, OCHzO), 6.68 (1H, s, H-8), 6.77 (lH, s, H-11)
13C NMR: (CD30D): 70.6 (CH, C-1), 72.0 (CH, C-2), 115.3 (CH, C-3), 146.9 (C, C-
3a), 29.3 (CHz, C-4), 54.5 (CHz, C-5), 57.6 (CHz, C-7), 130.4
(C, C-7a), 108.3 (CH, C-8), 148.1 (C, C-9), 146.9 (C, C-10),
105.9 (CH, C-11), 127.5 (C, C-11a), 41.5 (CH, C-11b), 62.6
(CH, C-llc), 102.4 (CHz, OCHzO), 20.6 (CH3, OCOCH3- 1),
171.6 (C, OCOCH3 - 1), 20.9 (CH3, OCOCH3- 2), 171.4 (C,
OCOCH3 -2)
74
2.5.4 PHYSICAL DATA FOR COMPOUND IV
NAME: cnnme
Yield: 47 mg
Melting point: 207 - 208°C (lit. 208 - 210 °c [5])
Optical rotation: [a]D = _16° (c=1.0, MeOH); lit = _9° (c=0.6, EtOH) [5]
DV: Amax (MeOH), (log E), 210 (3.89), 291 (3.15),230 (3.01)
--.:::::_1
Mass: [M+] at m/z 271, CI6H17N03 r5lquires 271
. 1/' + +
EIMS: m/z (reI. mt.): 271 (100) [M ], 254 (7.78) [M - OH],
240 (20.21), 228 (20.21) [M+ - CH2CH2NH], 199 (86.58) [M+ -
CH2CH2NH - HCHO], 173 (27.46) [M+ - CH2CH2NH -
HCHO - C2H2] , 141 (18.08), 115 (36.64), 98 (2.11), 77
(18.10),56 (29.34), 39 (11.29)
Infra red: vmax (cm-I): 3350, (0 - H stretching), 2928, (aliphatic C - H
stretching), 1496 (aromatic C=C stretching), 1238 (C - N
stretching), 1036 (C - 0 stretching), 941 (C - 0 - C stretching)
IH NMR: (CDCh): 1.74 (lH, ddd, H-4~, J = 4.2, 13.8, 13.8), 1.86 (1H, m, H-
llexo), 1.98 (lH, brd, H-4a, J = 13.8), 2.20 (lH, ddd, H-llendo,
J = 4.0, 9.0, 13.2), 2.93 (lH, m, H-12endo), 3.30 (1H, d, H-
12exo, J = 12.6), 3.38 (lH, dd, H-4a, J = 3.8, 13.8), 3.81 (1H,
d, H-6~, J = 16.9), 4.35 (1H, m, H-3), 4.43 (lH, d, H-6a, J =
16.9), 5.89 (2H, d, OCH20, J = 2.2), 5.96 (lH, dd, H-2, J=
5.4,10.0),6.47 (lH, s, H-7), 6.53 (lH, d, H-1, J= 10.0),6.83
(lH, s, H-10)
13C NMR: (CDCh): 131.7 (CH, C-1), 127.8 (CH, C-2), 63.7 (CH, C-3), 32.6 (CH2,
C-4), 62.8 (CH, C-4a), 62.0 (CH2, C-6), 125.9 (C, C-6a), 106.9
(CH, C-7), 145.8 (C, C-8), 146.2 (C, C-9), 102.9 (CH, C-10),
138.1 (C, C-10a), 44.3 (C, C-10b), 43.9 (CH2, C-11), 53.4
(CH2, C-12), 100.8 (CH2, OCH20)
75
2.5.5 PHYSICAL DATA FOR COMPOUND V
NAME: crinamine
Yield: 107 mg
Melting point: 190°C (lit. 190 - 192 °c [5])
Optical rotation: [a]D = +1660 (c=1.0, MeOH ); lit = +1800 (c=0.55, CHC!) [5]
UV: Amax (MeOH), (log E), 210 (3.89), 240.5 (3.44),291.2 (3.59)
Mass: HRMS: [M+] at m/z 301.1298, C17H19N04 requires 301.1313
ElMS: m/z (reI. int.): 301 «1) [M+], 270 (37.03) [M+ -
OCH3], 269 (100.00) [M+ - CH30H], 268 (28.49) [M+ -
CH30H - H], 252 (17.49), 250 (11.08), 240 (28.20) [M+ -
CHOH - OCH3], 226 (32.41) [M+ - OCH3- CHOHCH2], 211
(13.80) [CI4Hll02t, 181 (26.10) [C13HI90t, 149 (7.47), 115
(6.05) 60 (12.45), 45 (11.88),43 (15.69)
Infra red: vmax (cm-I): 3400, (0 - H stretching), 1630, 1492 (aromatic
C=C stretching), 1241 (C - N stretching), 1044 (C - 0
stretching), 945 (C - 0 - C stretching)
IH NMR: (CD30D): 2.08 (lH, m, H-4a), 2.15 (lH, dd, H-4P, J= 13.06,10.44),3.23
(1H, dd, H-12exo, J = 13.73, 3.45) 3.28 (lH, dd, H-4a, J =
13.25, 3.30), 3.42 (3H, s, OCH3), 3.50 (lH, dd, H-12endo, J =
13.73, 6.16), 3.73 (1H, d, H-6a, J = 16.91), 4.00 (1H, dd, H-
11 endo, J= 6.17,2.75),4.10 (lH, m, H-3),4.33 (lH, d, H-6P, J=
16.61),5.91 (2H, s, OCfuO), 6.11 (1H, d, H-2, J = 10.32),6.31
(lH, dd, H-1, J= 10.44,2.13),6.56 (1H, s, H-7), 6.89 (lH, s,
H-10)
13C NMR: (CD30D): 125.8 (CH, C-1), 134.2 (CH, C-2), 77.6 (CH, C-3), 30.6 (CH2,
C-4), 67.4 (CH, C-4a), 61.5 (CH2, C-6), 126.6 (C, C-6a), 107.8
(CH, C-7), 147.8 (C, C-8), 148.2 (C, C-9), 104.3 (CH, C-10),
137.2 (C, C-10a), 51.7 (C, C-10b), 81.0 (CH, C-l1), 63.6 (CH2,
C-12), 55.8 (CH3, OCH3), 102.2 (CH2, OCH20)
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2.5.6 PHYSICAL DATA FOR COMPOUND VI
NAME: hamayne
Yield: 12 mg
Melting point: 80°C (lit. 82 - 84 °c [5])
Optical rotation: [a]D = +800 (c=0.5, MeOH); lit = +790 (c=0.52, EtOH) [5]
UV: Amax (MeOH), (log E), 211 (4.24.),241.5 (3.58),290.7 (3.59)
Mass: ElMS: m/z (!el. int.): 287 «1) [M+] (CI6H17N04/, 270 (l9.03)
[~ - OH], 269 (100.00) [~ - H20], 268 (29.11) [M+ - H20 - H],
240 (28.94), [M+ - CHOH - OH], 211 (14.83) [C1J11102t, 181
(36.97) [C13HI90t, 149 (16.19), 115 (8.24) 57 (7.40),43 (8.13)
Infra red: vmax (cm-I): 3400, (0 - H stretching), 1478 (aromatic C=C
stretching), 1235 (C - N stretching), 1044 (C - 0 stretching),
1037 (C - 0 stretching), 945 (C - 0 - C stretching)
IH NMR: (CD30D): 2.11 (lH, m, H-4a), 2.20 (lH, dd, H-4~, J= 13.43,10.44),3.38
(lH, dd, H-12exo, J = 13.73, 3.42), 3.48 (lH, dd, H-4a, J =
13.62,4.40),3.66 (lH, dd, H-12endo, J= 13.73, 6.96), 3.95 (lH,
d, H-6a, J= 16.48),4.05 (lH, m, H-11 endo), 4.37 (lH, m, H-3),
4.47 (lH, d, H-6J3, J = 16.48), 5.93 (2H, s, OC!hO), 6.09
(lH,d, H-2, J = 10.31), 6.25 (lH, dd, H-1, J = 10.38, 2.26),
6.60 (lH, s, H-7), 6.92 (lH, s, H-10)
BC NMR: (CD30D): 122.9 (CH, C-1), 137.4 (CH, C-2), 67.0 (CH, C-3), 33.2 (CH2,
C-4), 65.6 (CH, C-4a), 63.0 (CH2, C-6), 125.2 (C, C-6a), 106.8
(CH, C-7), 146.3 (C, C-8), 146.8 (C, C-9), 103.3 (CH, C-10),
135.4 (C, C-10a), 49.8 (C, C-10b), 79.5 (C, C-11), 60.5 (CH2,
C-12), 101.0 (CH2, OCH20)
77









280 cC decomposes (lit. 280 - 285 cC [45])
Amax (MeOH), (log E), 258 (3.47),268 (3.18), 279 (4.45), 340
(4.33)
EIMS: 250 (8.27) [~], 249 (61.09) [M+ - H], 248 (lOO) [M+ -
2H], 190 (18.92),163 (9.01),123 (9.89),95 (18.17),63 (3.11)
Ymax (cm-I): 3402 (due to water of crystallization), 1486, 1271,
1039 and 917 cm-1 (C - 0 - C stretching)
IH NMR: (CD30D): 8.54 (lH, d, H-1, J = 8.2), 7.94 (lH, t, H-2, J = 7.1), 7.86
(lH, d, H-3, J = 7.0),3.85 (2H, t, H-4, J = 6.6), 5.27 (2H, t, H-
5, J= 6.6),9.64 (lH, s, H-7), 7.79 (lH, s, H-8), 8.32 (lH, s,
H-11),6.39 (2H, s, H-12)
13C NMR: (CD30D): 120.5 (CH, C-1), 131.5 (CH, C-2), 126.1 (CH, C-3), 136.9 (C,
C-3a), 27.5 (CHz, C-4), 55.8 (CHz, C-5), 145.1 (CH, C-7),
123.1 (C, C-7a), 107.4 (CH, C-8), 157.4 (C, C-9), 151.1 (C, C-
10), 101.2 (CH, C-11), 133.7 (C, C-11a), 124.1 (C, C-11b),
136.89 (C, C-11c), 104.52 (CHz, C-12)
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An introduction to triterpenoids
3.1 Introduction to terpenoids
Terpenes are a class of compounds that can be isolated from plants. Oxygen-
containing terpenes are referred to as terpenoids [1,2]. Terpenoids are typically found
in all parts of a plant i.e. seeds, flowers, foliage, roots and wood of higher plants.
They also occur in mosses, liverworts, algae and lichens and some are of insect or
microbial origin [3]. The terpenoids form a large and structurally diverse family of
natural products derived from Cs isoprene units [4]. The terpenoids can therefore be
conveniently classified according to the number of isoprene units in the carbon
skeleton (table 3.1) [3].
Table 3.1: Classes of terpenoids [3]
There are more than 22000 known triterpenoid structures [5]. Each of which
originates from isopentenyl pyrophosphate (IPP). The study of terpenoids is made
more complex because the functions ofmost of the terpenoids present in plants are
not known. Some of these compounds may at one time have served as defensive
agents against predators, such as insects, that no longer exist. It is also possible that
some terpenoids are chemical by-products of biochemical transformations in plants
that are not as well tuned as those in mammals [5].
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Over the past sixty years, terpenoids have provided the substrate for numerous studies
on the fundamentals of mechanistic organic chemistry, for example on the nature of
carbocations and their rearrangements, on the relationships between structure and
colour and on the Woodward - Hoffmann rules for correlation of orbital symmetries
during organic reactions. Commercially, triterpenoids have been used in the
manufacture of perfumes, soaps, flavourants, colourants, disinfectants, detergents and
in many pharmaceuticals [3].
Lanosterol is a biologically important triterpenoid compound. It is the biosynthetic
precursor of cholesterol. Lanosterol cannot be broken into isoprene units because
migration of methyl groups occurs in its biochemical precursor. Cholesterol is
derived from lanosterol by a process that removes three methyl groups. Because
cholesterol contains only twenty-seven carbons, it is not a triterpenoid and is properly
referred to as a trinortriterpenoid [5].
A number of terpenoids, with very complex structures, have been shown to have
potent activity in inhibiting cancerous cell division. Often, these compounds are too
toxic to be of value in chemotherapy. Taxol is a well known exception, which is
effectively used as a chemical agent for suppressing the growth ofhard tumors. Taxol
is found only in very small amounts in the bark of the pacific yew tree. Three trees
are required to isolate sufficient taxol for the treatment of one patient [5].
Taxol
Figure 3.1: The structure of taxol
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3.2 Biosynthesis of terpenoids
Terpenoids are derived from isoprene units. Isopentenyl pyrophosphate (IPP) and
dimethylallyl pyrophosphate (DMAPP) are the reactive intermediates in the pathways
leading to more complex terpenoid structures. These isoprene units combine to yield
several classes of terpenoids, as illustrated in scheme 3.1 [4]. Isoprene units are
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Scheme 3.1: The biosynthesis of terpenoids
Since only triterpenoids have been isolated in this work, only their biosynthesis will
be considered.
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loss ofproton geranyl pp
(GPP)
opp
Scheme 3.2: The formation of geranyl pyrophosphate
Combination of DMAPP and IPP via the enzyme prenyl transferase yields geranyl
pyrophosphate (GPP) (scheme 3.2). The mechanism involves ionization of DMAPP
to the allylic carbocation. This carbocation is then added to the double bond of IPP.
The loss of a proton yields GPP. Stereochemically, the proton lost (HR) is the same as
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Scheme 3.3: The formation of farnesyl pyrophosphate
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Geranyl pyrophosphate can react with another molecule of isopentenyl pyrophosphate
to form famesyl pyrophosphate (FPP), a fifteen carbon compound. The reaction
proceeds in an analogous manner to that ofGPP formation (scheme 3.3).
Two molecules of famesyl pp are joined III a tail-to-tail fashion to yield the
hydrocarbon squalene (scheme 3.4). A proton from a C-l position of one molecule of
FPP is lost, and a proton from NADPH is inserted. The mechanism involves the
addition of the 2,3-double bond ofFPP on to the famesyl carbocation in an analogous
manner to the chain extension using IPP. The resultant tertiary carbocation is
discharged by the loss of a proton and formation of the cyclopropane ring, forming
presqualene PP.
Loss of pyrophosphate from presqualene pp yields a primary carbocation. This
carbocation then undergoes a Wagner-Meerwein rearrangement resulting in stability
from ring expansion as well as from the generation of the more favourable secondary
carbocation. This is the followed by bond cleavage in the cyclobutane ring, thus
producing a favourable allylic carbocation. The generation of squalene is then





























I .1 bond cleavage produces alkene
\ .~\ andfavourable allylic carbocation
e 1H carbocation quenched by(NADPH) attack ofhydride
squalene
Scheme 3.4: The formation of squalene [4]
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Cyc1isation of squalene occurs through the intennediate squalene-2,3-oxide. It is
produced in a reaction catalysed by a flavoprotein requiring oxygen and NADPH as
cofactors. Protonation of the epoxide group, opens up the epoxide ring and in doing
so generates the preferred tertiary carbocation. Electrophilic addition to a double
bond then occurs and this results in the fonnation of a six member ring (scheme 3.5).
This process continues, generating a new carbocation after each ring is fonned, until a
tertiary dammarenyl carbocation is reached. Wagner-Meerwein rearrangements then
occur in the dammarenyl carbocation to yield the baccharenyl carbocation.
Although this involves the sacrifice of a tertiary for a secondary carbocation, the
reaction proceeds in this way as some ring strain is relieved by the fonnation of a six
member ring. A pentacyc1ic ring system can now be fonned by cyclization on to the
double bond, giving a new five member ring and the tertiary lupenyl carbocation.
Enzymes are actively involved and facilitate each step in the biosynthesis [4].
Loss of a proton from the lupenyl carbocation gives lupeol (XI) (scheme 3.6). Lupeol
can then be oxidised to yield lupenone (XII), which is further oxidised to yield
glochidone (XIII). Lupeol can also be oxidised to yield 3p,27-dihydroxylup-20(29)-
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CHAPTER 4
Extractives from Cyrtanthus brevijlorus
Cyrthantus brevifJorus
4.1 A review of previous work
Plants of the family Amaryllidaceae are widely distributed in southern Africa [1].
The Amaryllidaceae plants occurring in southern Africa belong exclusively to the
tribes Amaryllideae and Haemantheae, which are two of nine tribes in this family
[1,2]. The tribe Haemantheae consists of the following six genera: Cyrtanthus,
Haemanthus, Clivia, Scadoxus, Gethyllis and Apodolirion [1].
The word Cyrtanthus is derived from the Latin words Kyrtos, meaning curved, and
from the word anthos, which refers to a flower. The genus Cyrtanthus is
characterized by few narrow leaves, buried bulbs, one to few flowers in the
inflorescence, flower tubes are narrow or trumpet-like and tepallobes are shorter than
the curved flower tubes [3]. Cyrtanthus is native to Africa and is found mainly in
South Africa. There are approximately fifty known species to date [3].
Bulbs of many species of the Amaryllidaceae family have been used in traditional
medicine in South Africa [1,4]. Cyrtanthus is no exception: C. breviflorus, C.
stenanthus, C. contractus, C. mackenii, C. tuckii and C. sanguineus are all reportedly
used by Zulu people as protective sprinkling charms against storms and evil spirits
[1,5]. Bulb infusions of C. sanguineus are taken regularly from the fourth month of
pregnancy to ensure an easy labour [5,6]. C. sanguineus is also a popular and
beautiful garden plant, which has been in cultivation since 1846 [3]. C. mackenii, C.
brachyscyphus, C. obliquus and C. obrienii are also popular garden plants [3]. Bulbs
of several Cyrtanthus species such as C. galpinii, C. stenanthus and C. tuckii are
edible [3]. The bulb of C. obliquus is one of the ingredients in a medicine for scrofula
and in another for troublesome chronic coughs. A decoction of the bulb alone is a
remedy for tubercular cough. Dried bulbs of C. obliquus are also made into a powder
and then rubbed onto fractures to aid in their healing [4]. The bulb of C. obliquus is a
South African remedy for cystitis and leprosy [1, 4]. Bulb infusions of this species
are also used for stomach aches [1,7].
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Cyrtanthus breviflorus Harv. is also known as Wild Crocus and Yellow Fire Lily.
The word breviflorus refers to short flowers [6]. The Zulu name for C. breviflorus is
"uvelabohleke" [3]. This plant is characterized by strap-shaped leaves which are
upright, long and narrow, growing to 200 mm. Attractive, golden-yellow funnel-
shaped flowers crown the tip of an erect 200 mm long peduncle. Flowering occurs in
spring. Plants are often found flourishing after a grass burn fire [6]. The bulbs of
Cyrtanthus breviflorus are very glutinous. C. breviflorus is often dormant during the
winter months [6]. C. breviflorus can be found in moist or dry grassland regions
along the coast from eastern Cape to Kenya [3]. C. breviflorus is a schedule two
protected species in South Africa [ 8].
The bulbs of C. breviflorus are used for urinary and chest complaints and the roots
below the bulb are used to treat broken limbs and sprains [6]. Bulb infusions are
taken as love charm emetics and are also used as protective sprinkling charms [5].
Bulbs are used to treat roundworm and tapeworm [1,5]. C. breviflorus has been
reported to be a dangerous plant, having been suspected of causing poisoning in cattle
[1,5].
Seven Cyrtanthus species have been examined phytochemically and seven different
alkaloids have been identified from them (table 4.1) [1]. The alkaloids from
Cyrtanthus can be classified into five distinct types: the lycorine, the homolycorine,
the haemanthamine, the narciclasine and the galanthamine type.
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Table 4.1: Previously identified alkaloids from Cyrtanthus
The lycorine type alkaloids
OH








Figure 4.1: Previously isolated lycorine type alkaloids from Cyrtanthus
Lycorine (1) is an ubiquitous alkaloid in the Amaryllidaceae family. Its isolation is
usually facile due to its relative insolubility in most organic solvents. Lycorine (1)
usually precipitates out from crude extracts [13]. Parkamine (2) is closely related to
1, except that methoxy groups are present at C-2 and C-ll.
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Figure 4.2: A previously isolated homolycorine type alkaloid from Cyrtanthus
Hippeastrin~ (3) has a characteristic 3a,4-double bond and an a hydroxyl group at
C-S. The orientation of the hydrogen at C.,Sa is a to the C ring. The bioactivity of
hippeastrine (3) is given in table 4.2.






Figure 4.3: Previously isolated haemanthamine type alkaloids from Cyrtanthus
Haemanthamine (4) is commonly isolated from the family Amaryllidaceae [1]. It has
a characteristic 1,2-double bond as well as a p-orientated methoxy group. The most
distinguishing feature of this alkaloid is the S,l Ob-ethane nitrogen bridge, which has
an a orientation. Haemanthidine (5) is isolated as a mixture of the 6a and 6P
hydroxyl isomers. The bioactivity of haemanthamine (4) and haemanthidine (5) is
given in table 4.2.
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Figure 4.4: A previously isolated narciclasine type alkaloid from Cyrtanthus
Narcic1asine (6) is distinguished by the presence of an amide group in ring B. The
bioactivity ofnarcic1asine (6) is given in table 4.2.
A galanthamine type alkaloid
OH
galanthamine (7)
Figure 4.5: A previously isolated galanthamine type alkaloid from Cyrtanthus
Galanthamine (7) is unique in that ring A and ring C are joined by a 10,1 ether
linkage. This alkaloid also possesses an a-orientated ethane nitrogen bridge. Ring C
contains a single double bond and an allylic hydroxyl group. The bioactivity of
galanthamine (7) is given in table 4.2.
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Table 4.2: The bioactivity of alkaloids isolated from Cyrtanthus species
® for the bioactivity of the lycorine type alkaloids see table 2.2.
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4.2 Results and discussion
Cyrtanthus breviflorus has not been investigated previously. Overall, little
investigation has been done on Cyrtanthus. Only seven alkaloids have been reported
previously from the genus i.e. lycorine (1), parkamine (2), hippeastrine (3),
haemanthamine (4), haemanthidine (5), narciclasine (6) and galanthamine (7) [1].
The marked role of Cyrtanthus in traditional medicinal usage prompted further
investigation [1]. The ethanol extract of the bulbs, leaves and roots of Cyrtanthus
breviflorus yielded four alkaloids, lycorine (I), haemanthamine (VIII), crinamine
hydrochloride (IX) and tazettine (X), after separation by column chromatography
over silica gel (figure 4.6). Crinamine hydrochloride (IX) and tazettine (X) have not
been reported previously from Cyrtanthus.
Figure 4.6: Compounds isolated from the ethanol extract of Cyrtanthus
breviflorus
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The hexane extract of Cyrtanthus breviflorus yielded five triterpenoids, lupeol (XI),
lupenone (XII), glochidone (XIII), 3~,27-dihydroxylup-20(29)-ene (XIV) and
betulinaldehyde (XV), after being subjected to column chromatography.











Figure 4.7: Compounds isolated from the hexane extract of Cyrtanthus
breviflorus
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Figure 4.8: COMPOUND VIII: haemanthamine
Compound VIII was isolated as white crystalline material (27 mg). Its physical and
spectral properties were consistent with those of haemanthamine [24].
Haemanthamine has been isolated previously from Cyrtanthus elatus and is frequently
isolated from the Amaryllidaceae family [1,10]. Spectra for compound VIII are given
on pages 209-218 in appendix A.
The mass spectrum of compound VIII showed a molecular ion peak at m/z 301 and
fragments at m/z 269, 257, 240, 227, 225, 211 and 181. The molecular ion peak
corresponded to the molecular formula of haemanthamine (C17H19N04).
Haemanthamine (VIII) is stereoisomeric with crinamine (V). The difference between
VIII and V is that in the former compound, the methoxy substituent on C-3 is in the p
position whereas in the latter compound it is in the a position. Thus both alkaloids
constitute a C-3 epimeric pair. Ghosal et al. and Duffield et al. have reported on the
similarities and differences in the mass spectrum of C-3 epimeric pairs of 5,1 Ob-
ethanophenanthridine alkaloids [22,23]. They have shown for C-3 epimeric pairs,
such as vittatine/epicrinine or haemanthamine/crinamine, that the first alkaloid in each
pair i.e. the alkaloid with the C-3 oxygen substituent in the p position, had its
molecular ion appear as a prominent peak in the mass spectrum. In the corresponding
epimeric pair i.e. the C-3 oxygen substituent in the a position, the molecular ion was
not detectable [22,23].
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However, it was reported that the rest of the fragmentation pattern is similar [23].
The fragments observed in the mass spectrum of haemanthamine (VIII) arise through
an analogous manner as that of crinamine (pages 51-54) [22,23].
The infra red spectrum of compound VIII was consistent with that of haemanthamine
[24]. The infra red spectrum showed bands at Vmax 3448 cm-
1 (0 - H stretching) and
1029 cm-1 (C - 0 stretching), 1483 cm-1 (aromatic C = C stretching) indicating the
presence of an aromatic ring, 1242 cm-1 (C - N stretching) indicative of carbon
nitrogen bonds and 929 cm-1 (C - 0 - C stretching), suggestive of the presence of a
methylenedioxy group.
The IH NMR data of compound VIII was consistent with that of haemanthamine
(table 4.3) [24]. The IH NMR spectrum, recorded in CDCb, showed three singlets in
the downfield region at ()H 5.86, 6.52 and 6.89. These resonances were assigned to
the protons of the methylenedioxy group and to the p-oriented aromatic protons, H-7
and H-I0, respectively. The HSQC correlation between the methylenedioxy group
protons and a methylene carbon resonance at ()c 101.10, as well as the NOESY
interactions between H-I0 and H-l/H-ll and the NOESY interactions between H-7
and H-6a/H-613 were consistent with their assignments.
The olefinic region also showed a doublet at ()H 6.44 (J = 10.1) which was assigned to
H-l and a double doublet at ()H 6.23 (J= 10.1,4.9), assigned to H-2. The splitting
pattern of the H-2 resonance is characteristic for compounds having a trans
orientation for the 5,10b-ethane bridge and the C-3 oxygen substituent (page 49). The
H-2 resonance is split by H-l and the H-3 proton. The H-3 resonance was observed
as a multiplet at ()H 3.85. The NOESY interaction between H-2 and H-3 confirmed
their assignments. NOESY interactions were also observed between the H-3 and the
two H-4 protons at ()H 2.14 and ()H 1.97. These resonances were assigned to H-4a and
H-413 respectively. The H-4a resonance was observed as a multiplet at ()H 3.30. This
resonance showed an HSQC correlation to a methine carbon at ()c 62.90. The
NOESY interaction between H-4a and H-413 confirmed their assignments.
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The H-6 protons were observed resonating as doublets (Jgem=16.7) at <>H 4.28 and <>H
3.76. H-6P was assigned to <>H 4.28 due to its NOESY interaction with H-4a. H-
11endo was assigned to the multiplet at <>H 3.94. The HSQC spectrum showed a
correlation between H-11 endo and a methine carbon at <>c 79.72. The NOESY
interaction between H-llendo and H-lO confirmed their assignments. The remaining
two resonances at <>H 3.44 and <>H 3.14 were assigned to the H-12 protons. H-12endo
was assigned to the more downfield resonance due to its NOESY correlation with H-
6u.
The BC NMR spectrum showed seventeen carbon atoms. Their chemical shifts were
consistent with those reported for haemanthamine (table 4.4) [25].
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Table 4.3: IH NMR data for compound VIII and literature data for
haemanthamine [24] (J given in Hz in parenthesis)
® IH NMR spectrum recorded in CD30D, 400 MHz.
®® IH NMR spectrum recorded in CDCi), 200 MHz.
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Table 4.4: BC NMR data of compound VIII and literature data for
haemanthamine [25]
® 13C NMR spectrum recorded in CD30D, 100 MHz.
®® 13C .NMR spectrum recorded III CDCi), 75 MHz.
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Figure 4.9: COMPOUND IX: crinamine hydrochloride
Compound IX was isolated as white crystalline material (13 mg). The IH NMR
spectrum of IX was similar to that of crinamine (V) with the exception that certain
resonances were shifted downfield. Pronounced downfield shifts were evident for the
protons surrounding the nitrogen atom, suggesting that compound IX was a crinamine
salt. The subsequent base treatment of IX yielded crinamine (V). Crinamine or its
salt has not been isolated previously from the genus Cyrtanthus . It is unlikely that
compound IX is an artefact, arising from crinamine, as no acid or base was used in the
extraction or isolation procedure. Spectra for compound IX are given on pages 219-
228 in appendix A.
The mass spectrum of compound IX showed a very weak molecular ion peak at m/z
301, consistent with a compound of the crinamine type [23]. The spectrum was very
similar to that of crinamine (V). The mass spectral fragmentation pattern was
previously discussed on pages 51-53.
The infra red spectrum of compound IX was similar to crinamine (V) [26]. The infra
red spectrum showed bands at Vmax 3322 cm-
1 (0 - H stretching) and 1038 cm-1 (C-
o stretching), 1492 cm-1 (aromatic C = C stretching) indicating the presence of an
aromatic ring, 1242 cm-1 (C - N stretching) indicative of carbon nitrogen bonds and
940 cm-
1
(C - 0 - C stretching), suggestive of the presence of a methylenedioxy
group.
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The IH NMR spectrum of compound IX, recorded in deuterated methanol, exhibited
three downfield signals at 8H 5.98, 6.57 and 6.84. These resonances were assigned to
the protons of the methylenedioxy group and to the p-oriented aromatic protons, H-7
and H-10, respectively. The HSQC spectrum suggested that these assignments were
correct. Furthermore, the assignments ofH-7 and H-10 were consistent with literature
[22,27]. In addition to this, a NOESY interaction was observed between H-10 and
the H-1 proton.
The olefinic protons, H-1 and H-2, were observed as a double doublet and a doublet
in the olefinic region of the IH NMR spectrum. Strong coupling between these
protons were observed in the COSY spectrum. H-1 is split by H-2 and H-3 (J= lOA,
2.7 Hz) whereas H-2 is split only by H-1 (J= lOA Hz). The dihedral angle between
H-2 and H-3 is approximately 90°, hence no coupling is observed. The resonances at
8H 6.15 and 8H 6.26 were accordingly assigned to H-1 and H-2 respectively. As
observed previously, the above splitting pattern is important because information
about the orientation of the 5,IOb-ethane bridge and the C-3 oxygen substituent can be
derived from it (discussed on page 49). From the splitting pattern it can be inferred
that the 5,10b-ethane bridge and the C-3 methoxy substituent have the same
orientation. This is consistent with the mass spectral suggestion.
NOESY correlations between the H-2 proton and the resonances at 8H 3.97 and8H
3.39 were observed in the NOESY spectrum. The HSQC spectrum showed a
correlation between the OH 3.97 resonance and a methine carbon. The resonance at OH
I
3.39 correlated to a methyl carbon'. This suggested that the methoxyl group was
located on C-3 and that H-3 resonated at 8H 3.97. The COSY spectrum showed that
the H-3 resonance coupled to two resonances at 8H 2.95 and 8H 2.32. H-4a and H-4P
were assigned to these resonances respectively. The HSQC spectrum suggested that
these assignments were correct. The NOESY correlation between the methoxyl group
protons and the H-4a proton was consistent with their assignments. The H-4 protons
were observed, in the COSY spectrum, to couple additionally with a resonance at 8H
3.70. This resonance was assigned to H-4a.
109
The HSQC spectrum showed a correlation between the H-4a resonance and a methine
carbon at ()e 67.2 suggesting that its assignment was correct. The H-6 protons were
observed resonating as doublets (geminal coupling) at ()H 4.11 and 4.76. The HSQC
spectrum showed a correlation between the H-6 proton resonances and a methylene
carbon. The lower field resonance was assigned to H-6P due to its co-planarity with
the nitrogen atom [28,29]. The NOESY correlation between H-4a and H-6P
confirmed their assignments.
The remaining resonance, at ()H 4.22, which had an HSQC correlation to a methine
carbon was assigned to H-11 endo. The two remaining H-12 protons were assigned to
the remaining resonances at ()H 3.64 and ()H 4.00. The HSQC spectrum was consistent
with these assignments. NOESY correlations were observed betwyen H-ll endo and H-
10/H-l confirming their assignments. COSY correlations were observed between H-
11 endo and the two H-12 protons, suggesting that their assignments were correct. H-
12endo was assigned to the resonance at ()H 3.64. The NOESY correlation between H-
ll endo and H-12endo confumed their assignments
Table 4.5 compares the 1H NMR data of crinamine hydrochloride (IX) with that of its
free base. Marked downfield shifts are observed for those protons that are spatially
proximate to the protonated nitrogen atom (shown in bold) i.e. the two H-4 protons,
the two H-6 protons, the H-11 proton and H-4a.
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Table 4.5: IH NMR data for compound IX and literature data for
crinamine [26] (J given in Hz in parenthesis)
® IH NMR spectrum recorded in CDCh, 400 MHz.
®® IH NMR spectrum recorded in CDCh, 300 MHz.
* A weak NOESY spectrum was obtained due to small amount of sample isolated.
1 1 1
Table 4.6: 13C NMR data of compound IX and literature data for
crinamine [26]
® l3C NMR spectrum recorded in CDCb, 100 MHz.
®® l3C NMR spectrum recorded in CDCb, 50 MHz.
Due to the strength of the sample, only a weak HMBC spectrum was obtained. This
spectrum was, nevertheless, sufficient to assign all carbon singlets fully. Protonated
carbons were assigned using the HSQC spectrum.
4.2.3 The structural elucidation of compound X
OMe
x
Figure 4.10: COMPOUND X: tazettine
Compound X was isolated as shiny brown needles (36 mg). The physical and spectral
properties of compound X were consistent with those of tazettine [1,30,31]. This is
the fIrst report of tazettine in Cyrtanthus. Tazettine has been isolated from a large
number of species in the Amaryllidaceae family [19]. Spectra for compound X are
given on pages 229-238 in appendix A.
The low resolution mass spectrum of compound X showed a molecular ion peak at
m/z 331, corresponding to the formula of ClsH21NOs. Significant peaks were also
observed at m/z 316, 298, 247 and 201. The peak at 316 is due to the loss of a methyl
radical i.e. [M+ - -CH3]. The peak at m/z 298 is due to the further loss of water i.e.













Scheme 4.1: Mass spectral fragmentation pattern of tazettine (X) [23]
The base peak in the mass spectrum of tazettine (X) occurs at m/z 247. A mechanism
consistent with high resolution spectral measurements is shown in scheme 4.2. The
double bond in ring C in tazettine rearranges. Ring C is then fragmented by a reverse












Scheme 4.2: Mechanism for the formation of the base peak in tazettine (X) [23]
The infra red spectrum of compound IX was consistent with that of tazettine and
pretazettine [31]. The infra red spectrum showed a broad band at Vmax 3329 cm-
l (O-
H stretching) and sharper bands at 1038 cm-l (C - 0 stretching), 1664 and 1493 cm-l
(aromatic C = C stretching) indicating the presence of an aromatic ring, 1249 cm-1 (C
- N stretching) indicative of carbon nitrogen bonds and 939 cm-1 (C - 0 - C
stretching), suggestive of the presence of a methylenedioxy group.
The lH, BC and DEPT NMR spectra showed signals for one methoxyl group, one N-
methyl, one methylenedioxy group, four olefinic/aromatic protons, two aliphatic
methines, three methylenes, four olefinic/aromatic quaternary carbons and two
aliphatic quaternary carbons, suggesting that compound X was a tazettine type
alkaloid. The methylenedioxy group protons and the aromatic, H-9 and H-12, protons
were obserVed as singlets at OH 5.87, 6.52 and 6.76 respectively. The resonance for
the methylenedioxy group protons was confirmed by the HSQC spectrum, which
showed the resonance to correlate to a methylene carbon resonance at Oc 101.2. The
NOESY correlation between H-12 and H-1 and between H-9 and H-8a/H-8p
confirmed their assignments. The H-8 protons were observed as a pair of doublets at
OH 4.95 and OH 4.62. The COSY spectrum showed strong coupling between these
protons. Due to the absence of vicinal protons, the NOESY spectrum could not be
used to differentiate between H-8a and H-8p. They were assigned by comparison to
literature [31].
The olefinic protons, H-1 and H-2, were observed as a pair of double doublets atoH
5.65 and OH 6.10 respectively. The COSY spectrum showed strong coupling between
H-1 and H-2. Weaker coupling between H-1 and H-3 and between H-2 and H-3 were
observed. H-3 was assigned to the multiplet at OH 4.13. NOESY interactions between
H-1 and H-2/H12 as well as those between H-2 and H-3 confirmed their assignments.
Additionally, H-2 showed a NOESY interaction with a methoxy proton group
resonance at OH 3.45. This suggested that the methoxy group was positioned at C-3.
The COSY spectrum showed H-3 coupling to two protons at ~H 2.30 and~H 1.60.
The HSQC spectrum showed these resonances to belong to geminal protons. These
resonances were assigned to the H-4 protons. H-4a was assigned to the more
downfield resonance. The NOESY interaction between H-4a and H-3a was
consistent with their assignments. The COSY spectrum showed strong coupling
between the H-4 protons and a resonance at ~H 2.98. This resonance was assigned to
H-4a. The NOESY interaction between H-4a and H-4P was consistent with their
assignments.
The singlet at ~H 2.49, which integrated for three protons, was assigned to the N-
methyl group. The presence of a N-methyl group in tazettine type alkaloids,
distinguishes them from the haemanthamine type, from which they formed
biosynthetically [32]. The NOESY spectrum showed interactions between the N-
methyl group and the H-4a, H-6P and the H-4a protons. The remaining pair of
doublets at ~H 3.30 and ~H 2.72 were assigned to H-6a and H-6P respectively. The
NOESY spectrum showed an interaction between the two H-6 protons and the N-
methyl group.
Table 4.7: IH NMR data for compound X and literature data for
tazettine [31] (J given in Hz in parenthesis)
® 'H NMR spectrum recorded in CD30D, 400 MHz.
®® 'H NMR spectrum recorded in CDCb, 90 MHz.
Table 4.8: 13C NMR data of compound X and literature data for tazettine [30]
® l3C NMR spectrwn recorded in CD30D, 100 MHz.
®® l3C NMR spectrwn recorded in CDCh, 75.5 MHz.
4.2.4 The structural elucidation of compound XI and XII
29~30 29~30








Figure 4.11: COMPOUND XI: lupeol and COMPOUND XII: lupenone
Compounds XI and XII were isolated as white crystalline materials. The physical
and spectral properties of XI were consistent with those of3~-hydroxylup-20(29)-ene
and the spectral properties of XII with that those of 3-oxolup-20(29)-ene.
Compounds XI and XII are commonly knoWn as lupeol and lupenone respectively.
Lupeol and lupenone are common triterpenoids and they are frequently isolated from
a wide range of plant species [33]. The difference between the tWo structures is the
substituent at C-3. In the case oflupeol, there is a ~-hydroxy group at C-3 whereas in
lupenone, there is a keto group. Spectra for compounds XI and XII are give on pages
239-244 and 245-246 in appendix A.
The high resolution mass spectrum of XI showed a molecular ion at 426.3867, which
was in agreement with the molecular formula C30HsoO. Significant peaks were also
observed at m/z 411,315,257,218,207,203 and 189. The base peak occurred at m/z
218. Compound XII decomposed before a mass spectrum could be obtained.
The infra red spectrum of compound XI showed peaks at Ymax .3379 cm-l (0 - H
stretching), 2929 cm- l (saturated C - H stretching) and at 1690 cm- l (isolated C=C
stretching).
The IH NMR spectrum suggested that compound XI had a lupane type structure
[34,35,36]. The IH NMR spectrum showed a vinylic methyl proton resonance at
()H 1.66. Resonances for six other methyl group protons were observed as intense
singlets at ()H 0.74, 0.77, 0.81, 0.92, 0.95 and 1.01. By comparison to literature, these
resonances were attributed to H-24, H-28, H-25, H-27, H-23 and H-26 respectively
[33].
Two broad singlets at ()H 4.55 and ()H 4.67 were assigned to the two non-equivalent
geminal protons of the terminal methylene group. The HETCOR spectrum showed a
correlation between the geminal protons and an olefinic methylene carbon at ()c 109.3,
confirming their assignments. In addition to this, the geminal proton resonances were
seen to be coupled to 3H-30, the vinylic methyl group proton resonance, in the COSY
spectrum.
The double doublet resonance observed at ()H 3.16 (J=5.4, 10.9) was assigned to H-
3p. A literature survey of similar lupane type compounds indicated that the observed
chemical shift and coupling constants were typical for such H-3a protons. In the
HETCOR spectrum, the resonance at ()H 3.16 was seen to be coupled to a methine
carbon at ()c 79.0. By comparison to literature, the multiplets at ()H 2.35 and ()H 1.90
were assigned to H-19 and H-21A respectively. The HETCOR spectrum was
consistent with these assignments.
The IH NMR spectrum ofXII was similar to that ofXI with the exception that the H-
3a resonance was missing. This suggested the presence of a keto group at C-3.
Comparison of the l3C NMR data confirmed the presence of a ketone group at the C-3
position. In lupeol (XI) the resonance for C-3 occurs at ()c 79.0 whereas in the
spectrum ofXII it occurs at 218.1.
The IH NMR spectrum revealed the presence of seven methyl proton group
resonances. The downfield shifted methyl resonance at ()H 1.66 was assigned to the
vinyl methyl protons at C-30. The remaining six methyl proton group resonances at
()H 0.77, 0.91, 0.93, 1.00, 1.05 and 1.23 were assigned, by comparison to literature, to
1,)()
H-28, H-25, H-24, H-27, H-26 and H-23 respectively. The vinylic protons, H-29A
and H-28B were observed as broad singlets at ()H 4.67 and ()H 4.55.
The 13C NMR spectrum indicated the presence of thirty carbons for XI and XII. The
13C NMR data for compounds XI and XII were assigned by comparison to literature
(table 4.10).
Table 4.9: IH NMR data for compounds XI and XII and literature data for
lupeol and lupenone [33] (J given in Hz in parenthesis)
® IH NMR spectrum recorded in CDCh, 300 MHz.
®® 1H NMR spectrum recorded in CDCh, 400 MHz.
®®®l .H NMR spectrum recorded m CDCh, 60 MHz.
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Table 4.10: 13C NMR data for compounds XI and XII and literature data for
lupeol and lupenone [33]
1 C NMR spectrum recorded in CDCh, 75 MHz.
18>18> BC NMR spectrum recorded in CDCh, 100 MHz.
18>18>18> 13 .C NMR spectrum recorded III CDCh, 25.2 MHz.
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Compound XIII was isolated as white crystalline material. The physical and spectral
properties of compound XIII were consistent with those of 1,20(29)-lupadien-3-one.
Compound XIII is commonly referred to as glochidone. Spectra for compound XIII
are given on pages 247-256 in appendix A.
The low resolution mass spectrum of compound XIII showed a molecular ion at m/z
422, which is in agreement with the molecular formula of C30H460. Significant
fragments occurred at m/z 405, 379, 311,285,229, 191, 150, 121 and 95. The base
peak occurred at m/z 150.
The infra red spectrum obtained for compound XIII was consistent with the proposed
structure. Peaks were observed at Vmax 2927 cm-
1 (saturated C - H stretching), 1466
and 1387 cm-1 (bending ofCH2 groups) and a strong peak was observed at 1677 cm-1
(C=O stretching).
The IH NMR spectrum suggested the presence of a lupane type structure [34,35,36].
The IH NMR spectrum of XIII was similar to that of XII except for a downfield pair
of doublets, at 8H 7.08 and 8H 5.76 (J=10.1). Two broad singlets were observed at 8H
4.57 and 8H 4.68.
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These resonances were assigned to the non-equivalent geminal H-29 protons. These
two resonances were seen to be coupled to a methylene carbon at Cc 109.7 in the
HSQC spectrum. The COSY spectrum showed long range coupling between the H-
29 protons and a vinylic methyl group at CH 1.67. The H-20 protons were assigned to
this resonance. The NOESY spectrum confirmed these assignments.
Six other methyl resonances were observed at CH 1.11, 1.09, 1.06, 1.05,0.94 and 0.79.
The resonances at CH 1.05 and 0.79 were assigned to the H-25'and H-28 protons
respectively. HMBC, NOESY and HSQC data were consistent with these
assignments.
The pair of doublets at CH 7.08 and CH 5.76, were assigned to the enonic protons, H-1
and H-2 respectively. NOESY, COSY, HSQC and HMBC data were consistent with
these assignments. The double double doublet at CH 2.38 was assigned to H-19. A
NOESY interaction was observed between one of the H-29 protons and the H-19
proton. The HMBC spectrum also· confirmed this assignment. The H-19 resonance
was seen to be coupled to a methylene proton at CH 1.90. This multiplet was assigned
to one of the H-21 protons. The NOESY and COSY spectra confirmed this
assignment.
The 13C NMR spectra indicated the presence of 30 carbons. The 13C NMR data for
compound XIII was assigned by comparison to literature (table 4.12).
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Table 4.11: IH NMR data for compound XIII and literature data for
glochidone [33] (J given in Hz in parenthesis)
® lH NMR spectrum recorded in CDCh, 400 MHz.
®® lH NMR spectrum recorded in CDCh, 400 or 90 MHz.
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Table 4.12: 13C NMR data for compound XIII and literature data for
glochidone [33]
l3C NMR spectrum recorded in CDCb, 100 MHz.
®® l3C NMR spectrum recorded in CDCb, 50 MHz.
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Figure 4.13: COMPOUND XIV: 3p,27-dihydroxylup-20(29)-ene and
COMPOUND XV: betulinaldehyde
Compound XIV was isolated as white crystalline material. XIV had consistent
spectral and physical properties with those of 3P,27-dihydroxylup-20(29)-ene [33,37].
3P,27-Dihydroxylup-20(29)-ene has been previously reported from Lithocarpus
cornea [36]. Compound XV was isolated as yellowish-white amorphous material.
Repeated column chromatography was only partially successful in purifying
compound XV. Compound XV was identified to be 3P-hydroxy-20(29)-lupen-28-al
and is commonly referred to as betulinaldehyde. Spectra for compounds XIV and XV
are given on pages 257-266 and 267-270, respectively, in appendix A.
The low resolution mass spectrum of compound XIV showed a molecular ion at m/z
442, in agreement with the molecular formula C30Hso02. Significant fragments were
also observed at m/z 411, 385, 288, 257, 234, 207, 189, 135, 95 and 69. The base
peak of XIV was observed at m/z 95. Compound XV decomposed before an infra
red, HETCOR, NOESY and mass spectrum could be obtained.
The infra red spectrum of compound XIV showed absorption bands at Vrnax 3450 cm-I
(0 - H stretching), 2942 and 2871 cm-I (saturated C - H stretching) and at 1690 cm-I
(isolated C=C stretching).
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The IH NMR spectrum of compound XIV and XV had similarities to that of lupeol
(XI); suggesting the presence of a lupane, type structure [34,35,36]. Comparison of
the IH NMR spectra of XIV and XV to that of XI suggested that one methyl group
had been oxidised to a primary alcohol for compound XIV and to an aldehyde for
compound XV.
Both the IH NMR spectra of XIV and XV showed a vinylic methyl group proton
resonance at approximately OH 1.66, and five other methyl resonances. In both cases,
the H-29 protons appeared as doublets at approximately OH 4.70 and OH 4.60 (Jgem=2.0
Hz). In the COSY spectra the H-29 protons were seen to be coupled to the terminal
vinylic methyl group resonance. In both IH NMR spectra, H-3 was observed at OH
3.16 as a double doublet (J=11.0,6.0). In the IHNMR spectrum of XIV, two proton
resonances were observed at OH 3.78 and OH 3.31. The HETCOR spectrum showed
these resonances to be coupled to a methylene carbon at Oc 60.5, suggesting a -
CH20H group. A comparison of the NMR data for compound xiv to that of lupeol
suggested that C-27 or C-28 possessed a hydroxyl group. The exact location of the -
CH20H group was determined using the NOESY spectrum. A NOESY interaction
was observed between the protons of the -CH20H and the vinylic methyl group. This
suggested that the -CH20H group was located at C-27 (from a molecular model).
Furthermore the C-28 position was ruled out as the IH NMR spectrum of compound
XIV was not identical with that of betulin [33,36,37,38]. Whereas the IH NMR of
betulin shows an H-19B resonance OH 2.99, compound XIV showed a H-19B
resonance at OH 2.35. Compound XIV was acetylated to yield the diacetate, thus
confirming the presence of two hydroxyl groups in the molecule. The l3C NMR data
ofcompound XIV compared favourably with that ofliterature (table 4.15) [37].
The IH NMR spectrum of compound XV showed a proton resonance at OH 9.66,
indicating the presence of an aldehyde group. The l3C NMR spectrum showed a
methine carbon at Oc 206.7, confirming the presence of an aldehyde group.
Compound XV decomposed before a HETCOR and NOESY spectrum could be run.
The carbon and proton NMR data were consistent with literature data for
betulinaldehyde (table 4.14 and table 4.15) [38,39].
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Table 4.13: IH NMR data for compound XIV and the literature data for
3~,27-dihydroxylup-20(29)-ene[33] (J given in Hz in parenthesis)
It
IH NMR spectrum recorded in CDCh, 400 MHz.
@® IH NMR spectrum recorded in CDCh, 300 MHz.
Table 4.14: IH NMR data for compound XV and the literature data for
betulinaldehyde [38] (J given in Hz in parenthesis)
H NMR spectrum recorded in CDCh, 300 MHz.
®® IH NMR spectrum recorded in CDCh, 90 MHz.
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Table 4.15: 13C NMR data for compounds XI and XII and literature data for
3~,27-dihydroxylup-20(29)-ene.and betulinaldehyde [37,39]
l3C NMR spectrum recorded in CDCh, 100 MHz.
18)18) l3C NMR spectrum recorded in CDCh, 62.9 MHz.
a, b, c,d _ values are interchangeable
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4.3 Conclusion
Whole plants of Cyrtanthus breviflorus were investigated. The ethanol extract of the
bulbs yielded four alkaloids, lycorine (1), crinamine hydrochloride (IX),
haemanthamine (XIII) and tazettine (X), after separation by column chromatography
over silica gel. Compounds IX and X have not been previously found in the genus.
Crinamine is isolated for the first time in its salt form (IX).
The hexane extract yielded five known pentacyclic triterpenoids: lupeol (XI),
lupenone (XII), glochidone (XIII), 3~,27-dihydroxylup-20(29)-ene (XIV) and
betulinaldehyde (XV). Triterpenoids have not been previously isolated· from
Cyrtanthus.
The four alkaloids isolated from Cyrtanthus breviflorus all display significant
bioactivity. Lycorine (I) is the most active. Haemanthamine (XIII) has been shown
to be cytotoxic against a variety of cultured cells [16,17,18]. Tazettine (X) is a known




Cyrtanthus breviflorus Harv. was obtained from Pinetown, Kwazulu-Natal and
identified by Dr. N. Crouch. A voucher specimen (Crouch 830) was deposited at the
Natal Herbarium. Whole plants (3.1 kg) were dried, and then finely cut and extracted,
first with hexane and then with 99% ethanol on a Labcon shaker for 48 hours each.
The extract was evaporated under reduced pressure.
Chromatographic separation of the hexane extract usmg a methylene chloride-
methanol step gradient (50:0, 49:1, 48:2, 46:4, 40:10) as the eluant and collecting
approximately 30 x 35 ml fractions for each step, gave lupenone (XII), present in
fractions 7-13, glochidone (XIII), present in fractions 15-22, lupeol (XI), present in
fractions 23-25, betulinaldehyde (XV), found in fractions 29-33 and 3B,27-
dihydroxylup-20(29)-ene (XIV), present in fractions 39-41.
Chromatographic separation of the ethanol extract usmg a methylene chloride-
methanol step gradient (19:1, 18:2, 16:4, 12:8, 10:10, 8:12, 0:20) as the eluant and
collecting approximately 30 x 35 ml fractions for each step, gave haemanthamine
(XIII), present in fractions 11-14, crinamine hydrochloride (IX), present in fractions
17-23, lycorine (I), present in fractions 44-51, and tazettine (X), found in fractions 64-
73.
4.4.1 The base treatment of compound IX
4M NaOH (2 cm3) was added to 10 mg crinamine hydrochloride (IX). The mixture
was shaken and then allowed to stand at room temperature for 10 minutes. The
mixture was then extracted with dichloromethane. The solvent was evaporated and
the base treated compound was analysed by NMR. The physical and spectral
properties of the base treated product were consistent with those ofcrinamine (V)
4.4.2 Acetylation of compound XIV
3B,27-Dihydroxylup-20(29)-ene (XIV), was acetylated. 3B,27-Dihydroxylup-20(29)-
ene XIV (20 mg) was placed in a round bottom flask with pyridine (3 cm3) and acetic
132
anhydride (3 cm3). The flask was heated on a steam bath for 10 minutes and then left
at room temperature for approximately 48 hours. Thereafter, excess acetic anhydride
was removed by the addition of methanol (3xlO ml). This was followed by the
removal of pyridine by adding toluene (3xlO ml). After each addition, the solvent
was evaporated off on the Rotavapor. Traces of toluene were then removed by the
addition of excess methanol. The sample was then spotted on a TLC plate to test for
the completion of the reaction.
Cyrthantus breviflorus (whole plants)
3.1 kg
i, macerate
ii. extract in hexane for 48 hrs
iii, extract in ethanol for 48 hrs
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4.4.3 PHYSICAL DATA FOR COMPOUND VIII
NAME: haernanthamine
Yield: 27 rng
Melting point: 201°C (lit. 203 - 203.5 °C [19])
Optical rotation: [a]D = +47° (c=1.0, MeOH); lit = +19.7° (c=3.25, MeOH) [19]
Mass: HRMS: [M+] at m/z 301.1310, C17HI9N04 requires 301.1314
ElMS: m/z (reI. int.): 301 «1) [M+], 269 (57), 257 (57), 258
(17),227 (93), 225 (70),211 (35), 181 (59)
Infra red: vmax (cm-I): 3448, (0 - H stretching), 1483 (aromatic C~C
stretching), 1242 (C - N stretching), 1029 (C - 0 stretching),
929 (C - 0 - C stretching)
IH NMR: (CD30D): 6.44 (lH, d, J=10.1, H-1), 6.23 (lH, dd, J=10.1, 4.9, H-2), 3.85
(IH, rn, H-3), 2.14 (lH, ddd, J=13.5, 9.2, 4.2, H-4a),1.97 (lH,
ddd, J=13.5, 9.0, 4.3, H-4~),3.30 (lH, m, H-4a), 3.76 (lH, d,
J=16.7, H-6a), 4.28 (lH, d, J=16.7, H-6~),6.52 (lH, s, H-7),
6.89 (lH, s, H-10), 3.94 (lH, m, H-11 endo), 3.14 (lH, dd,
J=13.9, 7.0, H-12exo), 3.44 (lH, dd, J=13.9, 3.2, H-12endo), 3.33
(3H, s, OCfu), 5.86 (2H, s, OC!hO)
13C NMR: (CD30D): 127.9 (CH, C-1), 129.4 (CH, C-2), 72.9 (CH, C-3), 27.8 (CH2,
C-4), 62.9 (CH, C-4a), 60.4 (CH2, C-6), 125.6 (C, C-6a), 106.7
(CH, C-7), 146.9 (C, C-8), 146.5 (C, C-9), 103.1 (CH, C-lO),
135.5 (C, C-10a), 50.3 (C, C-10b), 79.7 (CH, C-11), 62.6 (CH2,
C12), 55.6 (CH), OCH)), 101.1 (CH2, OCH20)
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4.4.4 PHYSICAL DATA FOR COMPOUND IX
NAME: crinamine hydrochloride
Yield: 13 mg
Melting point: 197 °c
Optical rotation: [a]D = +133 0 (c=O.5, MeOH )
Mass: HRMS: [M+] at m/z 301.1298, C17H19N04 requires 301.1313
ElMS: m/z (reI. int.): 301 «1) [M+], 270 (37.03), 269
(100.00), 268 (28.49), 252 (17.49), 250 (11.08), 240 (28.20),
226 (32.41), 211 (13.80), 181 (26.10), 149 (7.47), 115 (6.05) 60
(12.45),45 (11.88),43 (15.69)
Infra red: vmax (cm-I): 3322, (0 - H stretching), 1493 (aromatic C=C
stretching), 1242 (C - N stretching), 1038 (C - 0 stretching),
94 (C - 0 - C stretching)
IH NMR: (CDCh): 2.95 (IH, m, H-4a), 2.32 (1H, dd, H-4P, J=13.0, 10.4), 4.00
(IH, m, H-12exo), 3.70 (1H, dd, H-4a, J=13.0, 2.9), 3.39 (3H, s,
OClL), 3.64 (IH, m, H-12endo), 4.11 (1H, d, H-6a, J=16.8),
4.22 (1H, m, H-ll endo), 3.98 (IH, m, H-3), 4.76 (IH, d, H-6P,
J=16.8), 5.98 (2H, s, OCfuO), 6.26 (IH, d, H-2, J=IOA), 6.15
(IH, dd, H-l,J=10.4, 2.7), 6.57 (lH, s, H-7), 6.84 (IH,s, H-I0)
BC NMR: (CDCh): 121.2 (CH, C-l), 137.2 (CH, C-2), 75.0 (C~, C-3), 27.8 (CH2,
C-4), 67.2 (CH, C-4a), 58.9 (CH2, C-6), 118.4 (C, C-6a), 107.4
(CH, C-7), 148.7 (C, C-8), 148.2 (C, C-9), 104.2 (CH, C-I0),
132.0 (C, C-I0a), 5.9 (C, C-lOb), 77.9 (CH, C-ll), 61.1 (CH2,
C-12), 56.2 (CH3, OCH3), 102.1 (CH2, OCH20)
Base treatment of crinamine hydrochloride (IX) yielded crinamine (V). The physical
data for crinamine (V) is given on page 76.
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4.4.5 PHYSICAL DATA FOR COMPOUND X
NAME: tazettine
Yield: 36 mg
Melting point: 210°C (lit. 210 - 211°C [19])
Optical rotation: [a]D = +97° (c=1.0, MeOH); lit = +150° (c=3.25, CHCh) [19]
Mass: LRMS: [M+] at m/z 331, C17H19N04 requires 331.368
ElMS: m/z (reI. int.): 331 (19.76), 316 (10.23), 298 (18.01),
272 (3.40), 247 (100.00), 230 (16.88), 201 (20.09), 181 (21.22),
153 (19.02), 135 (6.01), 115 (28.66), 96 (3.89), 70 ( 32.67), 42
(28.00)
Infra red: Vmax (cm-I): 3329, (0 - H stretching), 1663 and 1492 (aromatic
C=C stretching), 1249 (C - N stretching), 1038 (C - 0
stretching), 939 (C - 0 - C stretching)
IH NMR: (CD30D): 5.65 (1H, dd, J=10.5, 2.0, H-1), 6.10 (1H, dd, J=1O.5, 2.0, H-
2),4.13 (1H, m, H-3a), 2.30 (1H, m, H-4a), 1.60 (lH, m, H-
4~), 2.98 (1H, m, H-4a), 3.30 (lH, d, J=11.7, H-6a), 2.72
(lH,d, J=10.8, H-6~), 4.95 (1H, d, J=14.5, H-8a), 4.62 (1H, d,
J=14.5, H-8~), 6.52(1H, s, H-9), 6.76 (lH, s, H-12), 5.87 (2H,
s, OCH20), 3.45 (3H, s, OCH3), 2.49 (3H, s, NCH3)
13C NMR: (CD30D): 129.0 (CH, C-1), 129.9 (CH, C-2), 72.5 (CH, C-3), 26.0 (CH2,
C-4), 70.9 (CH, C-4a), 64.7 (CH2, C-6), 101.1 (C, C-6a), 61.6
(CH2, C-8), 126.0 (C, C-8a), 103.9 (CH, C-9), 146.6 (C, C-10),
146.8 (C, C-l1), 108.8 (CH, C-12), 127.6 (C, C-12a), 49.8 (C,
C12b), 101.2 (CH2, OCH20), 55.4 (CH3, OCH3), 42.1 (CH3,
NCH3)
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4.4.6 PHYSICAL DATA FOR COMPOUND XI
NAMES: 313-hydroxylup-20(29)-ene, lupeol
Yield: 18 mg
Melting point: 210 QC (lit. 215 - 216 QC [19])
Mass: HRMS: [M+] at m/z 426.3867, C30HsoO requires 426.3862
EIMS: m/z (reI. int.): 411 (11.00),218 (100.00), 203 (24.12)
Infra red: Vmax (cm-I): 3378, (0 - H stretching), 2929 (saturated C - H
stretching), 1690 (isolated C=C stretching)
IHNMR: (CDCh): 3.16 (lH, dd, H-3, J = SA, 10.9), 0.95 (3H, s, H.,23), 0;74
(3H, s, H-24), 0.81 (3H, s, H-25), 1.01 (3H, s, H-26), 0.92
(3H, s, H-27), 0.77 (3H, s, H-28), 4.55 (lR, brs, H-29A), 4.67
(lH, brs, H-29B), 1.66 (3H, s, H-30)
13C NMR: (CDCh): 38.7 (CH2, C-1), 27A (CH2, C-2), 79.0 (CH, C-3), 38.8 (C, C-
4),55.3 (CH, C-5), 18.3 (CH2, C-6), 34.2 (CH2, C-7), 40.8 (C,
C-8), 50A (CH, C-9), 37.1 (C, C-10), 20.9 (CH2, C-11), 25.1
(CH2, C-12), 38.0 (CH, C-13), 42.8 (C, C-14), 27.7 (CH2, C-
15), 35.5 (CH2, C-16), 43.0 (C, C-17), 48.3 (CH, C-18), 47.9
(CH, C-19), 150.9 (C, C-20), 29.8 (CH2, C-21), 40.0 (CH2, C-
22),28.0 (CH3 C-23), 15.3 (CH3, C-24), 16.1 (CH3, C-25), 15.9
(CH3 C-26), 14.5 (CH3 C-27), 18.0 (CH3, C-28), 109.3 (CH2,
C-29), 19.3 (CH3, C-30)
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IH NMR: (CDCh): 1.23 (3H, S, H-23), 0.93 (3H, S, H-24), 0.91 (3H, S, H-25),
1.05 (3H, S, H-26), 1.00 (3H, S, H-27), 0.77 (3H, S, H-28),
4.67 (lH, S, H-29A), 4.55 (lH, S, H-29B), 1.66 (3H, S, H-30)
BC NMR: (CDCI3): 39.6 (CH2, C-l), 34.1 (CH2, C-2), 218.1 (C, C-3), 47.3 (C, C-
4), 54.9 (CH, C-5), 19.6 (CH2, C-6), 33.5 (CH2, C-7), 40.7 (C,
C-8), 49.7 (CH, C-9), 36.8 (C, C-I0), 21.4 (CH2, C-ll), 25.1
(CH2, C-12), 38.1(CH, C-13), 42.9 (C, C-14), 27.4 (CH2, C-
15), 36.5 (CH2, C-16), 42.9 (C, C-17), 48.2 (CH, C-18), 47.9
(CH, C-19), 150.8 (C, C-20), 29.8 (CH2, C-21), 39.9 (CH2, C-
22), 26.6 (CH3, C-23), 21.0 (CH3, C-24), 16.9 (CH3, C-25),
15.7 (CH3, C-26), 14.4 (CH3, C-27), 18.0 (CH3, C-28), 109.4
(CH2, C-29), 19.3 (CH3, C-30)
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4.4.8 PHYSICAL DATA FOR COMPOUND XIII
NAMES: 1,20(29)-lupadien-3-one, glochidone
Yield: 41 mg
Melting point: 165°C (lit. 164 - 165 °c [19])
Mass: LRMS: [~] at m/z 422, C30HsoO requires 422.693
ElMS: m/z (reI. int.): 405 (7.06), 379 (6.16), 311 (6.76), 285
(10.09), 229 (87.25), 191 (43.46), 150 (100.00), 121 (80.47) ,
95 (81.08)
Infra red: Vmax (cm·
i
): 2927, (saturated C - H stretching), 1466 and 1387 .
(CH2bending), 1677 (C=O stretching)
IH NMR: (CDC!J): 7.08 (1H, d, H-1, J = 10.1), 5.76 (lH, d, H-2, J = 10.1), 4.68
(1H, hrs, H-29), 4.57 (lH, hrs, H-29), 2.38 (lH, ddd, H-19, J=
11.0, 7.2, 1.8), 1.90 (lH, m, H-21), 1.05 (3H, s, H-25), 0.79
(3H, s, H-28), 1.67 (3H, s, H-30)
13C NMR: (CDC!J): 160.0 (CH, C-1), 125.3 (CH, C-2), 205.6 (CH, C-3), 44.9 (C,
C-4), 53.6 (CH, C-5), 19.5 (CH2, C-6), 34.1 (CH2, C-7), 42.0
(C, C-8), 44.7 (CH, C-9), 39.8 (C, C-IO), 21.5 (CH2, C-11),
25.4 (CH2, C-12), 38.5 (CH, C-13), 43.2 (C, C-14), 27.6
(CH2, C-15), 35.8 (CH2, C-16), 43.4 (C, C-17), 48.4 (CH, C-
18),48.1 (CH, C-19), 150.9 (C, C-20), 30.1 (CH2, C-21), 40.2
(CH2, C-22), 28.1 (CH3, C-23), 21.7 (CH3, C-24), 19.3 (CH3,
C-25), 16.7 (CH3, G·26), 14.7 (CH3, C-27), 18.3 (CH3, C-28),
109.7 (CH2, C-29), 19.6 (CH3, C-30)
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4.4.9 PHYSICAL DATA FOR COMPOUND XIV
NAMES: 3~,27-dihydroxylup-20(29)-ene
Yield: 22 mg
Melting point: 210-211 °c (lit. 214 - 215°C [19,33])
Mass: LRMS: [M+] at m/z 426, C30HSOO requires 426.3862
ElMS: m/z (reI. int.): 411 (11.00),218 (100.00), 203 (24.12)
Infra red: V rnax (cm-I): 3378, (0 - H stretching), 2929 (saturated C - H
stretching), 1690 (isolated C=C stretching)
IH NMR: (CDC!J): 4.66 (lH,d, H-29, J = 2.0), 4.55 (lH, d, H-29, J = 2.0), 3.78
(lH, d, H-28, J= 10.7), 3.31 (1H, d, H-28, J= 10.7), 3.16 (lH,
dd, H-3,J = 11.0,6.2), 1.66 (3H, s, H-30), 1.01 (3H, s, H-27),
0.96 (3H, s, H-26), 0.88 (3H, s, H-23), 0.80 (3H, s, H-25), 0.77
(3H, s, H-24)
13C NMR: (CDC!J): 38.7 (CH2, C-1), 27.4 (CH2, C-2), 79.0 (CH, C-3), 38.9 (C, C-
4), 55.3 (CH, C-5), 18.3 (CH2, C-6), 34.2 (CH2, C-7), 40.9 (C,
C-8), 50.4 (CH, C-9), 37.1 (C, C-10), 20.8 (CR2, C-11), 25.2
(CH2, C-12), 37.3 (CH, C-13), 42.7 (C,C-14), 27.0 (CH2,C-
15),29.1 (CH2, C-16), 47.8 (C, C-17), 47.8 (CH, C-18), 48.7
(CH, C-19), 150.5 (C, C-20), 29.7 (CH2, C~21), 33.9 (CH2, C-
22), 28.0 (CH3, C-23), 15.4 (CH3, C-24), 16.1 (CH3, C-25),
16.0 (CH3, C-26), 60.5 (CH2, C-27), 14.7 (CH3, C-28), 109.7
(CH2, C-29), 19.1 (CH3, C-30)
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sample decomposed (lit. 192-193 QC [19])
8mg
9.66 (lH, s, H-28), 4.74 (lH, d, H-29, J = 2.0) , 4.61 (IH, d, H-
29, J= 2.0),3.16 (lH, dd, H-3, J= 11.0,5.3),2.84 (IH, ddd, H-
19, J = 11.0,11.0, 6.0), 1.67 (3H, s, H-30), 0.95 (3H, s, H-24),
0.94 (3H, s, H-23), 0.89 (3H, s, H-26), 0.80 (3H, s, H-25), 0.73
(3H, s, H-27)
38.7 (CH2, C-l), 27.4 (CH2, C-2), 79.0 (CH, C-3), 38.9 (C, C-
4), 55.3 (CH, C-5), 18.3 (CH2, C-6), 34.3 (CH2, C-7), 40.8 (C,
C-8), 50.5 (CH, C-9), 37.2 (C, C-10), 20.8 (CH2, C-11), 25.5
(CH2, C-12), 38.7 (CH, C-13), 42.6 (C, C-14), 29.3 (CH2, C-
15), 28.8 (CH2, C-16), 59.3 (C, C-17), 48.1 (CH, C-18), 47.5
(CH, C-19), 149.7 (C, C-20), 29.9 (CH2, C-21), 33.2 (CH2, C-
22), 28.0 (CH3, C-23), 15.3 (CH3, C-24), 15.9 (CH3, C-25),
16.1 (CH3, C-26), 14.3 (CH3, C-27), 206.7 (CH, C-28), 110.2
(CH2, C-29), 19.0 (CH3, C-30)
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Spectrum [2-D]: COSY spectrum of l-O-acetyllycorine (11) in CD30D
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w Spectrum [2-F]: Infra red spectrum of l-O-acetyllycorine (H)
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Spectrum [3-F]: Infra red spectrum of 1,2-di-O-acetyllycorine (Ill)
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Spectrum [5-D] COSY spectrum of crinamine(V) in CD)OD
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Spectrum [5-r]: HETCOR spectrum of crinamine(V) in CD)OD
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Spectrum [6-H] Mass spectrum of hamayne(VI)
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Spectrum [7-1-1]: Expanded HMBC spectrum of anhydrolyconnium
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Spectrum [8-17] HSQC spectrum of haemanthaminc (VU}) in CD)OD
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Spectrum [8-1] Inll'a red spectrum of haemanthamine (VIII)
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Spectrum [9-1-11: Infra red spectrum ofcrinClmine hydrochloride (IX)

































Spectrum [9-1] Mass spectrum of crinamine hydrochloride (IX)
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Spectrum [I O-DJ COSY spectrum oftazettine (X) in CDCh
--~. __l..J_,--L,- 1L._L ~_._•.Jl~,_JlJ~__~
·-1
Fl
( (J pm J
-






































































7.0 6.5 £i.0 5.5 5.0 lI.S lI.O 3.5 3.0 2.5 2.0 1.5 1.0
F2 (ppm)
























I . I I ' I ' , I . , ' I . I I ' , I I . I,
0 lJ'") = lJ'") = lJ'") 0::: lJ'") = lJ'") c::;
N N t"? t"? <::" <::" lJ'") lJ'") l.O l.O "-
...,











































6 t{\0 , 0
' 0" ~ ,/11
o &/' ~
,09 • m
" ' =;.?l~ ~
. ,/11
.. £l
I , J1 . Q (l" 0 a











,41 ~ " o






1\ . 5 1\ .. 0
B
"
, -, , 1-' -, .. '--'-'1,-,... -.- -, - I " ......, ". '·,-,-r--,.rT-'-'--'--'''T " -, -, ....,...,--..-,......,_.J












































































I -lI 25 -:-l
I ~ ;
I :l ;




t 15~", 1"T-1""'I"""'"'''' I""'''' 1 .... 1 1'1.'.. ",.]".. , ,·,T"I··' .. ··I·!· .. ·•..r·'·' .. '.. I.. ' .. ' .. I·I'TTI·l ..'·'·'-TT-'-r"O'T.-rOO'-T-"'·'·"'''''''··'-''·11,
4000 3800 3600 3400 3200 3000 2800 2600 2400 2200 2000 1800 1600 1400 1200 1000 800
Wave numbers (cm-1)













Scan 1783 (14.555 min): TAZZ.D (-)
247




01 230 2r 331
°~~I~~II\~JJII"J~~~~I~I.~jU~,~ 11 'I~jHt Jl~~ Ilh~r'TnT~lll, I ' ?o~?o ,,,,~~~ I ' ~,~ ?~~~,1~~ I ' ~~~o ,~~~ ,,,,~~~ 1~1H I '



















.~~......1". '. 'J, ,
r-rr,~r I I I I I I , I "rrr-r"-"-r-f'--I-rr~r"''''-r-rr''I''--'-'''l-''-''Trl--r'-r,-r''-I-rr-rr-r-'-"'I"....--,---T-,·, I I I ,-,-,-('1 , , I r I I I I I I I I I
10 9 0 'I (j 5 11 3 2 1 PPH 0

































I i , I
l.0












































I I i ' I
~.o
I i I I I I
3.5 30
I I I !
2.5





I i I I
1.0
















102 _r--~~--------- --.------- ----.---.-.------- _._- .._- - ---0·'----- . __ . _
\.:
H






.-/ _., __JV,__. .-r."V"'y\
~ 90 \; I
I r 94 -j 3378.855 I
I a - I
I~ 92 ~ \ I
Im !
: i 90 ~ I
It 1 -i
t ~l
~ 88 - \ H
c 86 - \ i
e ~ I
: 84 j \ J
I 02
I \1
\ 80 . ~929"110.L. 4oo~;~;~~~·~·~O;-~;~~;- ·~·;.~;..;-~~~ ..;-~~~-;.~~~-;;-~~-;-~~-~-11-~~~···1~.~'~~"1~'~;-;' -1,;-~~;' "~-~~~-~';~'-
Ylavenumbers (cm-1) .








...' ,..,' ~,;;. .-,-,o-:'~'a9·gTITg~l=trN1IZ,Filler=[Range:0-450. Excl: ReflEx.] .
































tl . I 257.22557 3'15.26787 I
1~\J~.A ~jW~I rJ 1~~~"JtAII'l~"r'lIJr-.l-'I'Lr-~-"hLrLr.IL
150 200 250 300 350 400
ill I I I I , .
'\50 Hr MIl






25 I rl' 26 113 I (j~ 22
~ n , I" " 17/ """
10 28





I I I J'-J\.-.... .... I I ;J
rr' I 1 ' I , :--rr-r-rr~T'.-'--r-r-t , I : I I r-r, : I I I , I :0-""-;,--" I I I , I , ;o-',-~:rrrro""'T,TTTTfI-,'I' I , , I I I I 'f I ' , I I I I. I I I I
































r--T----r--. . I ,~l--r·--l--.,-----r----r---T-l--r-r--~----r--,~-.--r--·T-_,·--·r-----.--·-·,-·-,--l--·.,...----.,--.--l-t---·r~-r-··I·-'--I-·-"··· ,.. 0. "r ·--r--·-r-.-.-r- I I
)9 .'8 7 6 5 4 3 2 1 Ppm






































































































































































































































~!.. r-.~. - e.i3
I




J I --- - ._~-- ..-._-F2























I-' I I , I i I I , i , I I I r-II ' I , I t, I T''-rr-r-T-r-r1 6 0 1 5 0 140 130 1 Z0 110 1 ,-r-'-'-r-,-.-r-rT'-'-'-T-I'·-,-,~~,,·-rr,·-rT"T-T
00 90 80 70 60. 50 40 30
F1 (ppm)











;; D 0 ~ . • "Q.B .. '... ' ... '., '.. ....
~
d ~'., , I I










Tl"'T'TT'··l· r- ~--'-I· "T" r-r ""'-'"'''1-'-' -,rrrrrtl""-n-rrTII,""""·'Tl-n·'"T11. -l-r-"-" '" rl-' ,.,·-'..,..-.-r',"T"'"l·••fI-r ·"T'..-rry.....--rn
200 lBO 160 140 120 100 BO 60 40 20
F1 (ppm)






t E UCl. Cl)Cl.
Cl.L '--' CI:l











































































































_~ • . •.• . • .__ .. •.__ ~.,.._.__. - ... --....:. ......._._...... __~. ._._ .."" __._ .• __._._. ..-...._ .... _ .. __ ._-... ... _. __ .. • J
"'--rTII--,-,--rrT·r,-rp'-T··''1-1-,-,.-r-r--r''r-,-,·,-,-r-r,.-r--rT-r·rT··-T-r..,-rl-.I-I··-r·'-T..l·-r·-....I-r-~'I-'-·r..r·r







































































, "I ' 11
I ., ! !!
if Hi:ilii
! i; m 11 l
I
',' ',I 11, ill il !I
l
:1: :1 "
41 i" :11 ,I I
I
: '! '::1 ,!I i
I l!~ :1 i; ,!
I I I: 'I I1
11 1 I I I1
I·i· I i· I.! I I'.' IJ. f 4~
=, I I. It 285 I
400001 '1
1
1,1.:: I 311 379!
i 20000 ,It : I I I :
l ';": . 'l :t , i ,~9 ,,51 I <05 451470 503 53054~ iIz-> °20 , ~o·· 6'0" 80' '1'001'20 '1'«) '1'60 ~'80 200 220 240260280300320340360380 400420 ~o 460 ;,ao 500 520 540 . '~:












































































r-" I' i I i i i" i , , I ' I I I ' I ' I j I j I I I i I I I I I i I I
200 180 160 140 120 100 80 60 40 20 ppm
Spectrum [14-B]: l3C NMR spectrum of3j3,27-dihydroxylup-20(29)-ene (XIV)
in CDCh
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Spectrum [14-G): IH NMR spectrum ofacetylated 3~,27-dihydroxylup-20(29)-ene
(XIV) in CDCIJ
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H NMR spectrum of betulinaldehyde (XV) in CDCb
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Spectrum [15-B] 13C NMR spectrum of betulinaldehyde (XV) in CDCh
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